Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1697750948413.pdf (India)
SECTION 3 EMERGING CHALLENGES 300 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH CHAPTER 9 GENETICALLY MODIFIED CROPS Lead Authors: Nathaniel Makoni, Jennifer Mohamed-Katerere Contributing Authors: Munyaradzi Chenje “Because biotechnology is such a revolutionary science, and has spawned such a powerful industry, it has great potential to reshape the world around us.

It is already changing agriculture and what many of us eat.
Any major mistakes could lead to tragic and perhaps permanent changes in the natural world.

For these reasons, future generations are likely to look back to our time and either thank us or curse us for what we do – or don’t do – about GMOs and biosafety.

Doing the right thing is not simple.” CBD AND UNEP 2003 INTRODUCTION However, achieving food security is about more than just fulfilling yield deficits.
Food security is having There is growing debate about the potential value of sufficient physical, social and economic access to safe, modern biotechnology, and in particular of transgenics, nutritious and culturally acceptable food (Witcombe in helping to achieve Africa’s development and food and Sanchez 2004) at the household level, without security goals.

The challenge facing policymakers is not having to resort to emergency supplies.
This demands only to understand what the technology can do, or has either adequate food production or food imports.

done elsewhere, but also to establish what Agricultural choices are as much about food quantity opportunities it presents to Africa.

as they are about nutritional needs, livelihoods, There are three critical issues.

First, whether or not culture, poverty, trade and sustainable development.
● genetically modified organisms (GMOs) offer a Genetic modification technology may be useful in Food security is sustainable food security option; second, what the addressing some of these aspects.

However, the having sufficient implications are of transgenic technologies for biosafety potential of such technologies is controversial.
There is physical, social and as well as for human health and well-being; and third, considerable uncertainty about the impact on human economic access the extent of existing African capacity to undertake and environmental health, and also whether these to safe, nutritious research, and effectively monitor and evaluate products will provide a sustainable solution to food and culturally genetically modified (GM) products and their use.

problems.

The risks and benefits associated with GM acceptable food.
Genetic modification techniques allow novel traits technologies are difficult to quantify.

● to be introduced into animals, crops and micro- As resources for public sector research decreases, Witcombe and Sanchez organisms.

These techniques can be used to improve and the values that promote private sector 2004 livestock, poultry and fish productivity as well as their development and interests become entrenched in resistance to disease.
Genetic modification is being global governance instruments, the growth of GM used in the forest sector to create pest resistance, technology and applications seems certain.

However, herbicide tolerance and wood quality traits (FAO the potential role of GM crops for Africa in promoting 2005).
Crops can be genetically engineered to improve food security and improved human well-being is far appearance, taste, nutritional quality, drought from clear, and it is uncertain how their adoption will tolerance, and insect and disease resistance.

Thus, GM impact on the sustainability of livelihoods and food crops are often held up as the solution to yield deficits.

production systems.
production systems.

This chapter focuses exclusively on SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 301 Box 1: Genetic modification – just one biotechnology Genetic manipulation is not new.
For millennia, farmers have relied on of the genetic structure of one organism through the insertion of a selective breeding and cross-fertilization to modify plants and animals gene from another organism and can be used to modify plants, and encourage desirable traits that improve food production and satisfy animals and micro-organisms.

A gene is a biological unit that other human needs (CBD and UNEP 2003).
determines an organism’s inherited characteristics.This process of Biotechnology includes a wide range of scientific techniques that are modification is called genetic recombination – it adds characteristics used in several fields including agriculture and medicine.

The that the original organism did not have.


The resultant organisms are Convention on Biological Diversity (CBD) defines biotechnology as: called “genetically modified” or “genetically engineered” or “living modified” organisms (LMOs) – these organisms have been “Any technological application that uses biological systems, genetically modified in a way that does not occur naturally.
living organisms, or derivatives thereof, to make or modify Modified non-living organisms include products such as drugs, products or processes for specific use.” vaccines and food additives, canned, processed and preserved foods.

Biotechnology techniques and products applicable in the health sector Agricultural biotechnology includes bio-fertilization, tissue culture, that may be of value in developing countries include molecular marker assisted breeding and transgenics.
For example, artisans diagnostics, recombinant vaccines, vaccine and drug delivery have exploited traditional fermentation techniques to transform techniques, sequencing pathogens, genomes, microbicides, grains into bread and beer, and milk into cheese.

Such intentional bioinformatics, recombinant therapeutic proteins and combinatorial modification of the natural world has contributed enormously to chemistry (Millennium Project 2005b).

Environmental management human well-being.


Transgenic applications involve the modification techniques that may be useful include bioremediation.

Sources: CBD and UNEP 2003, Mackenzie and others 2003, UN 1992, UN Millennium Project 2005b the debates around GM and food security; its other GM crop areas was higher in developing countries than possible uses are not discussed.
in developed ones, developing countries accounting for The challenge for policymakers is how to respond to slightly more than one-third of the world’s GM crop this uncertainty about the relative opportunities and area.

(James 2004).
(James 2004).

Land under GM crops is expected threats posed by GM technologies: the dilemma is to continue increasing as the sector grows in India and whether to adopt this new technology and face criticism China and new countries introduce GM crops (James for lack of precaution, or to require thorough study of 2004).

In 2004, soybean accounted for 60 per cent of potential risks and face criticism for failing to act all GM crops, maize for 23 per cent and cotton for promptly (Young 2004).

11 per cent.
11 per cent.

In the near future, GM maize is projected to have the highest growth rate as more beneficial traits become available and are approved (James 2004).

STATE-AND-TRENDS GLOBAL GROWTH IN COMMERCIALIZATION OF GM CROPS Despite a steady increase in global plantings of transgenic crops from 1996, when they were first introduced, the global percentage of land under GM crops remains relatively small.

Figure 1 shows global plantings.


Genetically modified crops account for only 4 per cent of total global cultivation (WHO 2005).

Global plantings of GM crops jumped by 20 per cent in 2004; this was the second largest yearly increase since commercial plantings began in 1996 (James 2004).
In that year, land under GM crops rose to Figure 1: Global area of biotech crops million hectares total industrial countries developing countries 90 80 70 60 50 40 30 20 10 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 81 million ha.
For the first time, the hectarage growth in Source: James 2004 302 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Figure 2: Biotech crop countries and mega-countries* 2004 1 USA* 47.6 million ha soybean, maize, cotton, canola 12 Mexico* 0.1 million ha cotton, soybean 16 Honduras <0.05 million ha maize 15 Colombia <0.05 million ha cotton 6 Paraguay* 1.2 million ha soybean 3 Canada* 5.4 million ha canola, maize, soybean 13 Spain* 0.1 million ha maize 17 Germany <0.05 million ha maize 11 Romania* 0.1 million ha soybean 5 China* 3.7 million ha cotton 7 India* 0.5 million ha cotton 14 Philippines* 0.1 million ha maize 10 Australia* 0.2 million ha cotton * 14 biotech mega-countries growing 50 000 hectares or more of biotech crops.
Source: James 2004 2 Argentina* 16.2 million ha soybean, maize, cotton 9 Uruguay* 0.3 million ha soybean, maize 4 Brazil* 5.0 million ha soybean 8 South Africa* 0.5 million ha maize, soybean, cotton In 2004, there were 8.25 million farmers involved in As shown in Figure 2, there are 14 countries growing GM crop production in 17 countries (James 2004).

over 50 000 ha of GM crops.

In 2004, Paraguay, Spain, Although 90 per cent of these farmers were from Mexico and the Philippines joined this group.
However, developing countries, only one of these countries, South global production is dominated by five countries.

The Africa, was in Africa.

The International Service for the USA with 59 per cent of global sowings has the largest Acquisition of Agri-Biotech Applications (ISAAA) predicts share of total land under GMO production.
It is followed that by the end of the decade, up to 15 million farmers will by Argentina with 20 per cent, Canada and Brazil with grow GM crops on 150 million ha in up to 30 countries 6 per cent each, and China with 5 per cent of land under (James 2004).

The global biotech crop market was worth GM crops globally.

US$4 700 million in 2004, and is projected to rise to In Africa, the use of GMO technology and its products US$5 000 million in 2005 (James 2004).

is still in its infancy.
South Africa is the only African Box 2: GM crops in Egypt Crops under field trials: ● Cucumber ● Maize (Zea mays) ● Maize ● Melon ● Musk melon ● Squash ● Sugar cane (Saccharum officinarum) ● Tomato (Lycopersicon esculentum) ● Wheat Crops approaching commercialization: ● Potato – Resistance to infestation by potato tuber moth ● Squash – Resistance to a major viral pathogen ● Potato (Solanum tuberosum) ● Maize – Resistance to stem borers ● Cantaloupe ● Cotton – Resistance to certain insects Source: Mansour 2005 SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 303 Box 3: Bt cotton in South Africa Bt stands for Bacillus thuringiensis, a toxin producing bacterium found about 2003, there was a rapid decline in the area under Bt cotton.
In the naturally in soils.

Scientist have isolated genes responsible for the period 2003-04, only 35 700 ha of cotton was planted, amounting to an production of this bacterium and inserted it through genetic 80 per cent reduction since 2000.

This is ascribed to low world prices modification into cotton and maize to increase pest resistance.
and droughts: in 2004 -05 the area planted was 21 700 ha, an Smallholder farmers in the Makitini Flats, South Africa have been extraordinary 40 per cent drop in area planted with cotton in one year growing it since 1997.

By 2003 it was estimated that about 75 per cent (Pschorn-Strauss 2005).

Reportedly, 90 per cent of smallholders who of South Africa’s cotton was Bt cotton (Pschorn-Strauss 2005).
In the planted Bt cotton are in debt; the total debt among small-scale cotton initial period, smallholder Bt cotton appeared to be very successful.

The farmers in northern KwaZulu-Natal was estimated at over US$3 million higher cost of Bt cotton seed was offset by lower chemical use and yield in 2004 (Pschorn-Strauss).

increases of between 20-40 per cent (Glover 2003).

However, from Sources: Glover 2003, Pschorn-Strauss 2005 country that is commercially producing GM crops.
Mali, Mauritius, Morocco, Namibia, Niger, Nigeria, However, Egypt is approaching commercialization of four Senegal, South Africa, Tanzania, Tunisia, Uganda, Zambia GM crops; these are potatoes, squash, yellow and white and Zimbabwe (African Centre for Biosafety 2005).

maize, and cotton (Mansour 2005).


Nine countries – Benin, Burkina Faso, Egypt, Kenya, In South Africa, under the Genetically Modified Morocco, Senegal, Tanzania, Zambia and Zimbabwe – Organisms Act of 1997, three transgenic crops – insect are known to have conducted field trials (African Centre or herbicide resistant cotton, maize and soybean – have for Biosafety 2005).
Supporting legislation and policy been approved for commercialization (Department of to regulate research and commercialization processes Health undated).

GM crop plantings are growing: in have not kept pace with these developments.
2004 South Africa had 500 000 ha under GM crops Private sector dominance has meant that most (James 2004) and growth continued in white maize agricultural biotechnology research focuses on used for food and yellow maize used for feed; soybean developed country concerns such as improved crop plantings increased from 35 per cent adoption rate in quality or management rather than drought tolerance 2003 to 50 per cent in 2004, whilst Bacillus or yield enhancement, and innovations that save labour thuringiensis (Bt) cotton stabilized with about 85 per costs (such as herbicide tolerance) rather than those cent of producers adopting it (James 2004).
that create employment (Nuffield Council on Bioethics RESEARCH AND DEVELOPMENT Globally, GM research and development (R&D) is led by six large multinational life science companies independently or in collaboration with the Advanced Research Institutes (ARIs) in the industrial countries.

These companies include Monsanto, Syngenta, Aventis, CropScience and Dupont.
A number of developing countries (such as Brazil, Argentina, China, India, Malaysia and the Philippines) have significant R&D programmes in biotechnology and transgenic crops.

An increasing number of African countries have GM R&D capacity.

South Africa, Zimbabwe, Kenya, Nigeria, Mali, Egypt and Uganda are widely acknowledged as being the lead countries.
As many as 24 other African countries have some GM R&D capacity and at least 20 are actually engaged in such research (African Centre for Biosafety 2005).

These countries include Benin, GM trial potatoes in Makhatini, South Africa.
Burkina Faso, Cameroon, Egypt, Ghana, Kenya, Malawi, Source: Biowatch 304 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Table 1: GM crop research in Africa Country and Project name Partners and Funders Research Objective Additional Information KENYA Insect-Resistant Maize Kenyan Agricultural Research Institute (KARI) Bt maize resistant to the Open field trials started in for Africa in collaboration with the International Maize stem borer May 2005.
KENYA BURKINO FASO EGYPT and Wheat Improvement Centre (CIMMYT).

Funded by Syngenta Foundation for Sustainable Agriculture.

KARI MONSANTO International Service for the Acquisition of Agricultural Applications.

Funded by USAID and Monsanto.

Government Authorities destroy crop in August 2005 due to spraying of restricted chemicals.
Transgenic virus-resistant sweet potato In 2003, Monsanto, Syngenta and Burkina Field tests of two Bt cotton Research has taken place Faso’s Institut National de l’Environnement varieties et la Recherche Agronomique (INERA).

without the involvement or consent of the national biosafety committee which is tasked with developing a national regulatory regime for GMOs.
Monsanto and Egypt’s Agriculture Genetic Multiple crops, insect Commercial introduction Engineering Research Institute (AGERI) resistance could take place as early as currently collaborating in field trials of Bt cotton.

2006.

Laboratory work is being done on GM potato, tomato, corn, faba bean, wheat, cucurbits and cotton.

Field trials are being conducted for insect- resistant potato and virus-resistant cucurbits.

GM crops will be available soon on the commercial level.
Sources: Odame and others 2003, Glover 2003a, GRAIN 2005, Mansour 2005 1999).

With the shift away from public sector research Resistant Maize for Africa (IRMA).

Insect-resistant to private sector research, agricultural research has research is seen as particularly important given the become increasingly profit-driven and less focused on losses that are suffered as a result of insect infestations.

needs fulfilment.
needs fulfilment.

There are an increasing number of In Kenya, for example, farmers lose about 15 per cent of research initiatives of African interest.

In Africa, the the maize crop to stem borers (Glover 2003a).

main GM crops of research and commercial interest are Research cooperation between developing sweet potato, maize, cotton, soybean, pigeon peas, countries and institutions or companies based in the bananas and tobacco.
Much of this research is based on developed world has been important in promoting public-private-partnerships (PPPs) as shown, for transgenic research in Africa.

For example, the Swiss selected countries, in Table 1.
These include projects on Federal Institute of Technology (SFIT) in Zurich plans to vitamin A rice, virus-resistant sweet potato and Insect- collaborate with researchers in Kenya, Nigeria, the UK Figure 3: Distribution of cassava mosaic virus SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 305 Angola Benin Cameroon Chad Congo Côte d’Ivoire Ghana Kenya Lesotho Mozambique Nigeria Rwanda South Africa Togo Uganda Zambia Zimbabwe Source: University of Arizona/College of Agriculture and Life Sciences 2003 and the USA on the African cassava mosaic virus Despite the growing interest in GM crops, non- (Sawahel 2005).
This virus is transmitted to cassava transgenic agricultural research remains the backbone of by whiteflies when they feed on the plant.

In parts of agricultural research in most African countries.

In Kenya, Eastern and Central Africa, epidemics of the disease for example, of the 17 biotechnology research and can lead to total loss of harvests.

Researchers at SFIT training projects only 2 use transgenic technologies have used genes from a virus that periodically (Odame and others 2003).
Researchers in Côte d’Ivoire devastates cassava crops to create cassava plants that and Madagascar are engaged in non-transgenic rice can resist the virus.

Cassava is an important food crop research to improve yield.
In Côte d’Ivoire, the in many parts of Africa and is strongly affected by Consultative Group on International Agricultural genetic erosion, pest infestation and plant disease Research’s (CGIAR) West African Rice Development because it is a vegetatively propagated crop (Aerni Association (WARDA) has used an “embryo rescue” 2005).

Genetically modified cassava could save technique to cross-breed African and Asian rice.

The new African farmers large economic losses.


So far, the only variety has several advantages over conventional African way to curb the virus is by intensive use of insecticide varieties including early maturity, improved pest to kill whiteflies.

But this can be prohibitively resistance, drought- and acid soil-tolerance and greater expensive for subsistence farmers and can threaten height (which makes it easier to pick by hand) (Glover their health and that of surrounding plants and 2003a).
Madagascar has implemented a system of rice animals (Sawahel 2005).

cultivation which through improved agronomic practices, Given biosafety concerns, some countries are and without the use of GM varieties or chemical inputs, investing in improving their research and monitoring has shown improved yields (Glover 2003a).

capacity.

Zambia, for example, has begun building a modern molecular biology laboratory to detect GMOs entering the country (Ngandwe 2005).
The goal of this GM FOOD AID Drought, inadequate water resources and poor soils, US$330 000 laboratory facility is to be accredited as a along with other economic and social pressures, have regional and national referral laboratory that will made food shortages a problem in many parts of Africa.

provide research and training in collaboration with the From 2002, GM crops have been offered as food aid.
University of Zambia and the Norwegian Institute of In Southern Africa, several countries have expressed Gene Ecology (Ngandwe 2005).

Other countries such concern about the use of GM crops as food aid, given as Madagascar have taken a more cautious approach, the lack of clarity about their potential impacts.

During banning the growing or importing of GM foods due to the drought of 2002-03, several countries opted to concerns over their effect on human health and the reject GM food aid.
In making their decisions, countries environment (Apps 2005).

considered not only the immediate issue of food 306 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Box 4: Some approaches to GMO foods and food aid in Africa ANGOLA – Banned imports of all GMO produce, except for food aid MALAWI – Banned GMO imports unless already processed or milled, provided it was milled.

The United Nations World Food Programme citing concerns over environmental contamination.
(WFP) reported that the additional cost of milling discouraged some MOZAMBIQUE – Banned GMO imports unless already processed or food donors.

milled, citing concerns over environmental contamination.

ETHIOPIA – Banned import of GMO food, saying it would undermine SWAZILAND – Has no restrictions on GMO imports.

farmers who already have their own traditional ways of fighting pests SUDAN – Has some restrictions on GM food aid.

and weeds.
and weeds.

Debate continues over whether GMO crops could help the TANZANIA – Is in the process of drafting legislation to govern the import country out of years of serious food shortages.

of GMO foods.

KENYA – Does not permit GMO food imports, but government is in final ZAMBIA – Banned import of all GMOs, citing concerns over stages of drafting legislation to govern the process of commercializing environmental impact and effect on human health.

In response, it is GMO products.


alleged that the WFP moved some non-GM food aid stocks out of LESOTHO – Banned GMO food imports unless they are already the country.

processed or milled, citing concerns over environmental contamination.

ZIMBABWE – Banned import of all GMO produce, except for food aid, MADAGASCAR – Banned growing or importing GMO foods due to provided it has already been milled.

concerns over the effect on human health and environment.
Source: Apps 2005, ERA 2005 shortages and the overall implications of GM crops for sustainable agriculture.

Participatory Ecological Land human and environmental health, but also future Use Management (PELUM-Tanzania, PELUM-Kenya, directions in agriculture, the implications of private and PELUM-Zimbabwe), Biowatch South Africa, and sector-led research, livelihood and development national consumer councils have all been key players.
options, ethical issues and rights concerns (Mohamed- Some approaches to GM food aid are identified in Katerere 2003).

Similarly, public concerns are raised Box 4.

Mozambique raised concerns about accepting about the relationship between GM crops and GM maize aid on biosafety and human health grounds and opted to ban its import.
Zambia refused to accept GM food aid in any form; Zimbabwe, Malawi and Mozambique refused to accept GM food aid unless it was milled, this being seen as a precaution to avoid any germination of whole grains and to limit impacts on biodiversity; Lesotho and Swaziland authorized the distribution of non-milled GM food, but not before it warned the public that the grain should be used strictly for consumption and not for cultivation; and in 2004, Angola and Sudan introduced restrictions on GM food aid.
Global anti-GM food campaigns have influenced public attitudes to GM foods in Africa.

Consumers International (CI), a worldwide federation of consumer organizations with 38 member organizations in about 22 African countries, has played an important role in shaping the debates around GM foods.
It advocates a legal regime in which all GM foods are subject to rigorous, independent safety testing, labelling and traceability requirements, and in which producers are held liable for the environmental or health damage which their products may cause (CI 2005).

There is growing acceptance of this approach globally.

Vegetable farmers planting coriander to repel insect pests, Sudan.
Source: FAO SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 307 Figure 4: GM status in Africa Morocco Algeria Tunisia Libya Egypt Senegal Gambia Guinea Liberia Burkina Faso Cape Verde Mauritania Mali Niger Chad Sudan Eritrea Nigeria Central African Republic Cameroon Djibouti Ethiopia Democratic Republic of the Congo Congo Kenya Tanzania Zambia Mozambique Ghana Togo Benin Uganda Rwanda Seychelles countries who have signed the biosafety protocol countries who have ratified the biosafety protocol countries with commercial GM plantings countries with GM trials countries with GM research activities Zimbabwe Madagascar Mauritius Namibia Botswana Malawi South Africa Swaziland Lesotho Source: data from African Centre for Biotechnology 2005, CBD 2006, James 2004 DRIVERS AND CONSTRAINTS insecurity, including the interplay between inadequate access to water, poor soil fertility, climate change, As elsewhere, globalization, trade liberalization and inadequate infrastructure, weak markets, poverty, deregulation, and the privatization of agricultural R&D HIV/AIDS and civil war, are inadequately taken into lie at the heart of the push of GM technologies into account in developing solutions.
The shortcomings of Africa.

Africa’s receptiveness is shaped by concerns such an approach and the value of interlinkages in about food insecurity, growing poverty and inadequate problem analysis as well as in defining solutions are nutrition as well as declining public agricultural research discussed in Chapter 8: Interlinkages: The Environment budgets and capacity.

and Policy Web.
and Policy Web.

Declining public sector African agricultural research, Although human development, food security and combined with the privatization of agricultural research, environmental health issues are often the focus of the has led to a focus on providing hi-tech solutions, marketing strategies of the main R&D companies, it is including transgenics, over other agricultural options unlikely that such altruistic concerns are driving their (Scoones 2005).
Globally-driven agricultural research investment.

The developing world, including Africa, is an and technology development, which defines Africa’s important potential market, as consumer and producer, food security problems as being primarily about yield, given that Europe is not receptive to GM products and poses the “quick fix” of GM crops as particularly that more than 70 per cent of Africa’s people are attractive.
The multiple stressors that are driving food engaged in agricultural production (IFAD 2001).

308 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH The high level of investment needed in GM research Intellectual Property Rights (TRIPS), domestic IPR and its application has constrained African legislation in many African countries remains weak.

participation and has led to research that primarily Many countries struggle with how to reconcile IPRs with focuses on developed country needs.
Transgenic farmers’ rights and other local interests.

There are research is very expensive when compared to more concerns that strong IPRs will entrench global traditional biotechnology techniques.

For example, the domination of world food production by a few IRMA project is estimated to have cost US$6 million companies and increased dependence on industrialized over 5 years and the transgenic sweet potato research nations.
IPR may place restrictions on farmers, including ● US$2 million, compared to the average funding of on their existing rights to store and exchange seed.

People accept tissue culture and marker technology projects costing Some of the challenges regarding IPR are discussed in new technologies on average US$300 000 (Odame and others 2003).

Box 5.
Box 5.

On the other hand, in some instances the because they The absence of a supportive policy and legal absence of a legal framework has encouraged research believe the potential framework is often cited as an inhibiting factor for the as biotechnology companies can act with few restraints benefits outweigh development of biotechnology.

On the one hand, and responsibilities.

For example, in 1998 Monsanto the potential risks.


biotechnology companies may be reluctant to invest in engaged in the planting of GM crops in Zimbabwe as ● costly research without the legal guarantee that they there was no regulation, although these crops were CBD and UNEP 2003 will be able to commercialize their products (Seshia subsequently destroyed when the government 2002) Supportive legislative frameworks for research established what had happened (Glover 2003a).
include not only clear rules for risk assessment and At a national and regional level, the lack of commercialization but also intellectual property rights adequately inclusive policy processes has contributed (IPR) (Yamin 2003).

Although IPR standards have been to a polarized GM debate.
Since the United Nations developed through the World Trade Organization’s Conference on Environment and Development (UNCED) (WTO) Agreement on Trade-Related Aspects of in 1992, civil society has been increasingly recognized Box 5: Intellectual Property Rights: potential conflicts and opportunities for resolution as an important partner in the development of environmental policy and practice.
Civil society organizations, globally and within Africa, have been very active in claiming this space around issues related to genetic modification.

A range of concerns has been Intellectual Property Rights affect how financial benefits are distributed.
The raised related to the debates around human health and approaches of the WTO and the CBD are quite different: biosafety as well as to the socioeconomic implications, ● The Agreement on Trade-Related Aspects of Intellectual Property Rights especially as they relate to issues of food security, (TRIPS) asserts IPR on life form, while the Convention on Biological Diversity livelihoods and human well-being.
As discussed in (CBD) asserts national sovereignty and thus by implication the right to prohibit Chapter 1: The Human Dimension, an increasing IPR on life forms.

number of intergovernmental African agencies, ● The CBD promotes equitably shared benefits from use of biological resources international organizations and national governments and protection of traditional knowledge; TRIPS promotes the private are recognizing the value of such approaches.
For appropriation of benefits and has no mechanism for acknowledging the role of example, Benin has established a five-year national traditional knowledge in the industrial use of genetic resources.
moratorium on the importation, commercialization and utilization of all GM products or products derived from However there are some opportunities for reconciling these differences: GMOs to give the country time to effectively debate, ● Article 1 of TRIPS provides some flexibility, allowing domestic law to exceed develop and implement national biosafety legislation minimum protection standards, a provision that could allow member nations (GRAIN 2004).

to enact legislation to protect traditional knowledge.
Another set of concerns relating to policy-making ● Article 27.2 of TRIPS allows for the exclusion from patent ability based on processes is the growing influence of the scientific and public order or morality.

private sector in policy development and how to ● Article 27.3b of TRIPS allows for the development of unique IPR protection balance this with public concerns.
Issues of public trust, systems for plants, animals and essentially biological processes, creating an accountability and transparency, as well as farmers’ and opportunity to develop alternative IPR regimes appropriate to the needs and consumers’ rights, underlie much of this.

conditions of traditional communities.

Source: GBDI and IITA 2000 In many arenas, public objection to and concerns about GMOs are important constraints to GM research and the commercialization of GM products.
Globally, these concerns focus on health and environmental SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 309 implications.

These concerns stem from the continuing high levels of uncertainty around impacts and risks as well as the poor dissemination and communication of available information.
No technology or human activity is completely risk-free; people accept new technologies because they believe the potential benefits outweigh the potential risks (CBD and UNEP 2003).

Public mistrust of private sector motives resulting from past private sector behaviour in potentially risky areas such as tobacco, pharmaceuticals and chemicals is also a factor (Mohamed-Katerere 2003).
Some are concerned about possible dumping by companies or nations in efforts to dispose of surplus stocks or to recoup the cost of R&D.

In Southern Africa, some governments have expressed similar concerns about GM food aid (Mohamed-Katerere 2003).

In Africa, public concerns have revolved around ethical issues, food security and livelihood concerns, farmers’ and consumer rights, and non-inclusive policy processes.
Farmers’ organizations in West African countries have, in voicing their objection to the introduction of GM crops, focused on a range of factors that undermine the productive agricultural sector, including European Union (EU) and US cotton subsidies, Farmers in Côte d’Ivoire select the NERICA rice varieties to grow during PVS trials.

Here they compare panicles of rice varieties during post-harvest evaluation.
and are beginning to look more critically at the dominant Source: World Bank model of cotton production, questioning the need for chemical inputs and looking for means to reduce their dependence on cotton (GRAIN 2004).
Researchers and An IUCN – The World Conservation Union (IUCN) farmers are successfully rebuilding agricultural practices report finds that the controversies are essentially in based on farmer knowledge and local resources that three areas (Young 2004): greatly reduce the use of pesticides (GRAIN 2004).
● The interpretation of science and specifically Given the magnitude of what is at stake, these whether GMOs are inherently safe or inherently concerns remain, despite the policy and regulatory dangerous from a human and environmental frameworks on environment and biosafety developed perspective; under the CBD in 1992 and its Cartagena Protocol in ● Economic analysis and in particular how to evaluate 2000, which specifically regulates the transboundary the cost-and-benefits associated with GMOs; and movement of living modified organisms.
● Socio-cultural impacts and biosafety implications OPPORTUNITIES AND RISKS There is much controversy about the opportunities and revolving around issues of food production and security, livelihoods, and human and environmental health.

MARKETS AND TRADE The uncertainty about the impact of growing GM crops risks posed by GM technology.

This results in part from on markets for other crops is a concern for many the lack of information to support policymakers and the countries.
The European Union’s de facto moratorium public in evaluating the options.

Much of the on new approvals for the production and import of information that is available is oversimplified and may GMOs is particularly important.

focus on just one aspect of the debate, thus making it an Traceability requirements, such as the EU’s 2003 unreliable source.

Better scientific information is often initiative on country of origin labelling, have impeded inaccessible to non-GM specialists.
A key challenge imports from the US where many GM crops are facing African countries is how to deal with this produced.

Traceability requirements are designed to information gap and how to evaluate the contradictory address problems of contamination of organic crops by information that is available.

GMO pollen drift, the use of contaminated seeds and 310 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH sloppy handling.
Such practices have been reported European corn borer destroys 7-20 per cent of the (Riddle 2002) and are a trade concern.

Increased world’s annual maize harvest (Ives and others 2001).

If commercialization of GMOs in Africa could threaten Bt can successfully control the corn borer, maize yields organic agriculture and agricultural exports to, for in Africa could increase significantly (Ives and others example, EU countries where GMO use remains 2001).
However, the potential of such innovations is restricted (Pruzin 2004).

highly contested.

An additional issue is the relationship between However, as the Brundtland Report cautioned as national safety standards and labelling requirements early as 1987, the challenge of improving food security and global agreements.

While the Cartagena Protocol is more than just increasing food production.
The allows members to develop more stringent safety Brundtland Report noted that globally agriculture does standards than those it provides, there is the risk that not lack resources but lacks the policy to match need such standards could be found to violate provisions of and production (WCED 1987).

Food production is the WTO agreements.

FOOD SECURITY An important challenge for much of Africa is how one closely linked to cultural and livelihood systems.
Crucial issues that need to be addressed include (Young 2004): ● The impact of reliance on GMOs to solve social and economic problems; improves food security.
Determining appropriate ● The impact of the cost of GM crop production; strategies requires a clear understanding of the nature of ● The implications of expensive R&D processes; ● the food security problem and an understanding of what ● The equitable sharing of benefits arising from the use The challenge of exactly GM crops can bring to addressing this.
Millennium of genetic materials conserved primarily in the improving food Development Goal (MDG) 1, target 2 seeks to reduce developing countries; security is more than chronic hunger by half from the 1990 baseline by 2015.

● The impact of GMOs on local livelihood systems; and just increasing food Genetic modification technology may contribute to ● The impact of GMOs on agricultural biodiversity.

production.
production.

food security goals through increasing crop yields, ● producing hardier crop varieties that can withstand The assumption that food shortages stem from a gap in WCED 1987) heat and drought, enhancing nutritional and medicinal food production and population growth is now widely value, and improving storability (UN Millennium Project challenged.

The problem of world hunger is not a 2005b).

Increasing crop resistance to insects and problem of food production but one of distribution.
The diseases and reducing weeds could help reduce crop world today produces more food per inhabitant than losses and reduce dependence on costly fertilizers and ever before: enough food is available to provide 1.9 kg herbicides, resulting in valuable savings for resource- for every person every day: 1.1 kg of grain, beans and poor farmers (Bernsten 2004).

For example, the nuts, about 0.4 kg of meat, milk and eggs and the same amount of fruits and vegetables (Altieri and Rosset 1999).
The real causes of hunger are poverty, inequality and lack of access to food and land.

Too many people are too poor to buy the food that is available (but often poorly distributed) or lack the land and resources to grow it themselves (Lappe and others 1998 in Altieri and Rosset 1999).

Genetically modified crops may be important from a developing country perspective because specific nutritional values can be added (UN Millennium Project 2005b).
One of the best known genetic enrichment food crops is vitamin A improved rice, also called “Golden Rice.” Insufficient vitamin A intake by children in developing countries is the leading cause of visual impairment and blindness, affecting over three million children in sub-Saharan Africa (SSA) (Muir 2003).

Pregnant women with vitamin A deficiency (VAD) face an increased risk of mortality as well as high risk of mother-to-child HIV transmission.
Thus, if effective, nutritionally enhanced “Golden Rice” could be one Cajanus cajan (Pigeon Pea) is a perennial legume.

This plant is drought-resistant, nitrogen fixing, and enhances soil fertility.

It requires low inputs and can be intercropped with traditional crops.

Source: A. Conti/FAO SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 311 Box 6: Will the use of Bt cotton result in less pest threats and pesticide use?
In 2002, Bt cotton was planted on 4.6 million ha worldwide, year, 36 per cent of the Bt cotton fields in the US were approximately 13 per cent of the global cotton area.

Almost sprayed with insecticides specifically targeting bollworms all of this Bt cotton acreage was sown to Monsanto’s and other caterpillar pests.

Farmers outside the US have “Bollgard” variety.

Bollgard is genetically modified to had similar experiences.

In the Indian state of Andhra produce the Cry1Ac toxin of Bacillus thuringiensis.
Pradesh, where Bt cotton was cultivated for the first time Monsanto has developed a second Bt cotton variety, in 2002, Monsanto’s Bollgard cotton failed to control “Bollgard II”, which produces two different toxins, Cry1Ac cotton bollworms.

and Cry2Ab.
and Cry2Ab.

In 2004, Dow Agro-sciences hopes to There are many important cotton insect pests for introduce “Widestrike”, another Bt cotton producing two which Bt cotton offers no control, such as sucking pests toxins (Cry1Ac andCry1F), while Syngenta is trying to like aphids and jassids.

These secondary pests can result introduce its Bt cotton, “VIP Cotton”.
in significant crop damage on Bt crops, which helps to The Bt toxins expressed by Bt cotton only target explain why insecticide use remains high in Bt cotton lepidopteran pests (caterpillars) and some lepidopteran fields.

In Australia, pesticide use against bollworms has pests are more susceptible than others.

Bt cotton has been declined, but farmers still spray their Bt cotton fields with shown to be effective against the tobacco budworm insecticides 4.6 times per year.
The adoption of Bt cotton (Heliothis virescens) and the pink bollworm (Pectinophora may even increase problems with secondary pests.

In the gossypiella), but less effective in controlling cotton Indian state of Andhra Pradesh, farmers growing Bt crops bollworms (Helicoverpa zea and Helicoverpa armigera), an had to spray more against aphids than farmers growing important cotton pest in West Africa.

This is why farmers conventional crops.


In the US, where insecticide use growing Bt cotton continue to use pesticides against against bollworms has dropped by half since the bollworms and continue to experience damage from these introduction of Bt cotton, total insecticide use has pests.

In the US, despite the use of supplementary remained stable due to the growing importance of insecticides, farmers growing Bt cotton lost around 7.5 per secondary pests.

cent of their crop to cotton bollworms in 2002.


During that Source: GRAIN 2005 important tool for addressing the MDG 5 on maternal countries, including Zimbabwe, is attempting to address health.

While genetically enriched crops can be an these shortcomings (Muir 2003).

important nutritional strategy, the efficacy of this Nutritional diversity may be threatened by GM approach is contested.
It remains to be seen whether licensing agreements and production systems which these crops will live up to the nutritional values push farmers to monoculture and thus reduce the demonstrated in the laboratory in real life.

“Golden variety of crops planted for household consumption.

Rice” is genetically modified to produce beta-carotene, The livelihood implications of adopting GM the precursor of vitamin A.

For beta-carotene to be technologies are still not fully understood.
converted to vitamin A, it requires a functional digestive Biotechnology is a technology under corporate control, tract, adequate zinc, protein and fat stores, adequate protected by patents and other forms of IPR, and energy, and protein and fat in the diet.
However, in therefore contrary to farming traditions of saving and populations that suffer from VAD, the overall dietary exchanging seeds (Altieri 2002); consequently there deficiencies act as barriers to the conversion (Gola has been considerable resistance by non-governmental 2005).

The question also arises as to whether this is the organizations (NGOs) and community organizations to most cost-effective and sustainable way to address the adoption of GM crops.
There are concerns about nutritional deficits (Muir 2003).

An alternative is to the impacts of the changing nature of agribusiness and promote the use of existing varieties of food crops with its impact on poor people and their food security.

high levels of beta-carotene such as sweet potato.


One Because hunger is primarily linked to poverty, lack of of the main factors constraining the inclusion of access to land, and the maldistribution of food, one adequate fruit and vegetable in rural peoples’ diets is concern is that biotechnology may exacerbate the problem of food storage.

Research in some inequalities underlying the causes of hunger.
Leading 312 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH GM companies have been rigorous in enforcing of mineral and organic fertilizers include accumulation contractual agreements around the use, storage and of dangerous or even toxic substances in soil.

This sale of GM seed and products.

Small-scale farmers have includes cadmium pollution from mineral phosphate been prosecuted in developed and developing fertilizers or from town or industrial waste products; countries (ERA 2005).
eutrophication of surface water, with its negative effect on oxygen supply, which threatens fish and other forms CHEMICAL USE Modern agriculture has had negative impacts on the of animal life; nitrate accumulation in groundwater, diminishing the quality of drinking water; and unwanted environment.
The high level of chemical inputs required enrichment of the atmosphere with ammonia from for improved varieties, developed under the green organic manures and mineral fertilizers, and with revolution, which replaced traditional varieties has had a heavy toll.

nitrogen oxide (N2O) from denitrification of excessive or wrongly placed nitrogen fertilizer (Finck 1992).
Transgenic agriculture promises to limit the environmental releases of damaging chemicals (Cullen 2004, Bernsten 2004, and FAO 2002) by reducing the BIODIVERSITY It is not known how GM technologies will impact upon need for pesticides and herbicides, and fertilizers.

biodiversity.

The CBD defines biodiversity as: However, these claims remain contested, as discussed, for example, in relation to Bt cotton, in Box 6.
Whether “The variability among living organisms from the incorporation of the pesticide into the crop itself all sources including, inter alia, terrestrial, rather than application on the soil will be environmentally marine and other aquatic ecosystems and the friendlier is not known (Young 2004).

The challenges and ecological complexes of which they are part; opportunities associated with chemical use are this includes diversity within species, between considered more fully in Chapter 11: Chemicals.
species and of ecosystems.” Africa currently uses 3.6 million tonnes of fertilizer, but the potential requirement to maintain average The introduction of a transgene into a recipient organism levels of crop production without depleting soil is not a precisely controlled process and can result in a nutrients is 11.7 million tonnes per year (Henao and variety of outcomes with regard to integration, Baanante 1999).
The negative environmental aspects expression and stability of the transgene in the host (FAO and WHO 2003).

The risks associated with modifying the genetic structure of crops are not well understood and there is little agreement on either the severity or likelihood of potential risks.

This controversy emanates from a scientific dispute about how “stable” GM crops are.

Several concerns can be identified.


First, GM technology could result in the contamination of crops through gene transfer – “genetic pollution” – and the development of “super weeds” (Altieri 2002, Porter 2005) and therefore have a negative impact on biodiversity.

A further concern about GM crops is that the genes could “escape” and, through cross-pollination, mix with non-GM crops or their weedy relatives.
For example, an herbicide- tolerant gene could be transferred to weeds in wild habitats, turning them into “super weeds” (ERA 2005).

There is evidence of the unintentional spread of genes from GM crops (Monroe 2004).

Second, transgenic crops modified to be resistant to a particular pest or disease may have a negative effect on non-target species that are harmless or beneficial.

For example, Bt maize pollen may be toxic to the Monarch Farmer fertilizing maize crop in Burkina Faso.
butterfly (Losey and others 1999).

Although the Source: P. Lowrey/FAO Monarch butterfly is native to Mexico, the United States SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 313 Figure 5: Biodiversity in mountain regions Number of species per 10 000 km2 < 1–1 000 < 1 000–3 000 < 3 000–5 000 Mountain eco-regions are exceptionally rich in biodiversity.

Source: Fleury 1999 of America and Canada (Manos-Jones 2004) it is 2005).
Bt crops have proven to be unstable and possible that other butterfly species in Africa can be ineffective; some insects, which survive Bt, transmit similarly affected.

On the other hand, the alternative to genetic resistance to their immediate offspring.

If Bt transgenic crops could be as harmful to the becomes ineffective as an implanted pest control environment.
For instance, the practice of routine strategy within one insect generation, then organic spraying of broad-spectrum insecticides is non-selective, farmers will be robbed of a valuable biopesticide.

and therefore kills all insects regardless of whether they Regional cases of Bt resistance have already been are beneficial or harmful to the crop (Ives and others reported (Spinney 1999).

Insects resistant to the 2001).


A British study on oilseed has recently concluded genetically modified Ingard Bt cotton were reported in that it is not the GM crops that harm wildlife but the Australia (Australian Broadcasting Corporation 2001).

herbicides sprayed on the crops that significantly reduce Indeed, GM plants are not behaving as intended: in the broad leaf weeds such as chickweed, a major bird 1996, Monsanto’s pest-resistant Bt cotton succumbed food (Brown and Gow 2005).
The magnitude of these to a heat wave in the southern US and was destroyed by GMO risks to non-target organisms, including beneficial bollworms and other pests (Spinney 1999).

In 1997, insects, is largely unknown as there have been no farmers who grew Monsanto’s herbicide-tolerant cotton comprehensive studies in Africa to date.

saw the cotton balls fall off their crops (Spinney 1999).
Third, pest resistance can occur with frequent use of Fourth, GM crops engineered to be resistant to any pest control product (Soil Association 2003b).

specific herbicides enable farmers to spray weeds Insects can develop resistance to toxins such as the Bt without damaging crops (Soil Association 2003a).

Weeds bacterium, reducing the effectiveness of this control are developing resistance to these herbicides, and rogue method.
In Australia, India and China, for example, GM plants that grow after a harvest (volunteers) have pests are becoming resistant to some GM cotton crops appeared and spread widely (Altieri 2002, ERA 2005).

In that have Bt genes inserted (Spinney 1999).


Research particular, GM oilseed rape volunteers have spread into the safety of GM crops using genes that produce quickly, and some plants have become resistant to toxins should precede commercialization and not follow several herbicides through cross-pollination (Brown and it.

Inbred pest resistance might also be toxic to people Gow 2005).

Elsewhere, GM cotton crops have failed to in the long term.
For example, long-term consumption impart protection from pests resulting in increased use of of peas, Lathyrus sativus, can cause paralysis if a toxin chemical sprays: farmers are making more frequent in the peas accumulates in people, as has happened in applications and reverting to older and more toxic Bangladesh and India (Messons cited by Sawahel chemicals (Soil Association 2003b).

314 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Fifth, GMOs could impact on genetic diversity.
The 2005b).

The sterile monocultures are much more likely increased competitiveness of GMOs could cause it to to succumb to disease, which could potentially wipe out damage biologically-rich ecosystems.

Transgenic crops entire plantations (Spinney 1999).

Some companies could encourage biodiversity loss through the have developed GM crop seeds that use GURT.
As a establishment of monoculture agriculture which result, farmers become dependent on large corporations replaces traditional crops and other established and must purchase new seeds every season (ERA 2005).

varieties (Altieri 2002).

Currently, the main potential In addition to social equity issues associated with these cause of loss of biodiversity is agricultural expansion, monopolistic tendencies, GURT may have environmental which destroys habitats.
The needs of a growing global risks and thus the technologies require further population have largely been met by bringing more land evaluation.

GM crops can be unstable (Hansen 2000, into agricultural production (Ives and others 2001).

GMWatch 2005) posing risks to other plants.


Proponents of GM crops highlight this and suggest that There are counter claims to all these concerns: the use transgenic crops may be able to help preserve of herbicide-resistant and pest-resistant crops is believed uncultivated habitats by increasing yields on land to have positive implications for biodiversity.

With non- already under cultivation (Ives and others 2001), herbicide tolerant (non-transgenic) soybean, farmers reducing the need for conversion.
must clear the weeds before planting their seeds.

With Sixth, ecological and health hazards are also posed by herbicide-tolerant soybean, however, the weeds can be genetic use restriction technologies (GURT) which are better controlled; farmers can plant the seeds by sowing commonly known as terminator technology (Mclean them directly in relatively undisturbed soil.

This 2005).
This 2005).

These organisms do not flower and fruit and conserves moisture and soil fauna and flora and also therefore provide no food for the multitude of insects, reduces water and wind erosion (Ives and others 2001).

birds and mammals that feed on pollen, nectar, seed and fruit, and will inevitably have huge impacts on biodiversity (Mclean 2005).
Sterile trees can still spread by asexual HUMAN HEALTH CONCERNS Given the uncertainty over the risks associated with means and the genes can spread horizontally to soil GMOs, it is not surprising that strong and often bacteria, fungi and other organisms in the extensive root polarized opinions are held around issues of food safety system of the trees, with unpredictable impacts on the and human health.

Consumer and environmental soil biota and fertility.
As transgenic traits tend to be organizations and several governments have adopted unstable, they could break down and revert to flower- cautious approaches to GM-derived foods, preferring to development, spreading transgenes to native trees, or err on the side of safety rather than take unknown risks.
creating pollen that poisons bees and other pollinators as Similar concerns have been expressed about the use of well as causing potential harm to human beings (ISIS GM ingredients in livestock production systems via incorporation of GM-derived oilseeds and cereals in animal feed.

The UK, Germany and France have eliminated the use of ingredients derived from GM plants from foods manufactured for direct human consumption or that enter the food supply chain (Soil Association 2003b).
Labelling of GM foods is an important consumer concern.

It provides information for consumers and users of the product and allows them to make an informed choice.

On this basis the EU, for example, has adopted labelling and traceability regulations (EC 2005).

In the late 1990s, Austria, France, Greece, Italy and Luxembourg imposed national bans on a number of GMO products.
Poland is the second central European country to ban a GMO maize type after Hungary, which outlawed the planting of Monsanto’s MON 810 hybrid seeds in January 2005 (Reuters 2005).

In the United States, labelling has not received the same level of attention.

In Africa, several countries have prohibited the import of GM foods, as shown in Box 4.

Consumer Genetic diversity in maize.


Source: CIMMYT SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 315 concerns about GM foods include health and ethical considerations (Mohamed-Katerere 2003).

Some human and animal health risks have been identified (Spinney 1999, Cox 1995).

Most of the examples are from regions where GMO technology has been in use far longer than it has in Africa.
This information provides important lessons for Africa – a region that is now a target for rapid expansion of GMO technology.

The limited experience with GMOs indicates some possible risks.

First, increased use of herbicide-tolerant GM crops may pose new risks for environmental and human health.

For example, glyphosate is a major formulation of “Roundup Ready” crops and is now the world’s best- selling “total” herbicide.
Due to the introduction of GMO-Roundup Ready crops, human and environmental exposure to the herbicide is expected to increase (Brown and Gow 2005).

However, there is strong The labelling of foods provides important information for consumers.

evidence that glyphosate-containing products are Source: bounford.com acutely toxic to animals and humans (ISIS 2005a).

Second, there are new medical risks from GM technologies.
For example, gene therapy involves the Fourth, increased antibiotic resistance may result.

For use of a virus to carry a modified DNA segment and the example, Novartis’ Bt maize contains a marker gene, virus is potentially pathogenic.

The risks of these which codes for antibiotic resistance in E.coli.

There is a treatments are largely unknown.


There are concerns risk that if animals or humans consume Bt maize-based that medical applications involving genetic engineering products such as cattle feed or starch, some antibiotics may produce cancer-causing genes from normal human would be rendered useless (Spinney 1999).

genes (Portfolio 21 2005).

Fifth, vitamin toxicity from nutritionally enhanced Third, the insertion of genes from one crop into crops may be an unintended consequence.
When GM another may increase allergic reactions, especially crops such as rice and rapeseed with high vitamin A where consumers are not informed about the origins of concentrations are planted, there will be no way to the transgene.

For example, soybean seeds genetically distinguish them from normal crops, with the contingent modified to include a gene from Brazil nuts in order to risk of liver damage if too much vitamin A is consumed fortify a protein supplement containing soy resulted in (Spinney 1999).
people allergic to Brazil nuts reacting to the soy product (Mills 2005).

The modified soy product indicated no negative reactions when it was tested on animals, ETHICS GMO and ethics issues centre among other things on illustrating the difference between the reactions of patenting, cloning of life forms and biopiracy.

These laboratory animals and humans to GM food products.
concerns have a direct bearing on achieving sustainable This warrants further study of this new technology livelihoods and conservation of environmental before it is widely embraced.

The soil bacterium resources.


In Africa, many communities and consumers Bacillus thuringiensis, from which endotoxin (Bt) genes express ethical concerns about “playing god” as plants are extracted and widely incorporated into GM crops as are transformed in unnatural ways and about the biopesticide, is a close relative of the anthrax implications for traditional beliefs and values.

bacterium, Bacillus anthracis, and exchanges genes If not properly managed, gene patents could be with it.
Potentially this can generate more deadly instrumental in promoting and institutionalizing social pathogens (Altieri 2002, ISP 2003).

Some Bt genes are inequity (Portfolio 21 2005, ERA 2005).

Patenting known to cause toxic or allergic reactions in humans genetic material traditionally available to a community, (ISP 2003).
However, GM technology can also be used without allowing the community free use of the material to prevent food allergies by deleting the major allergen, or providing any return to the community, affects the such as the case with soybean developed by Pioneer fair and equitable distribution of resources, a necessity International (Mills 2005).

in the development of a sustainable society 316 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH (ERA 2005).
There is concern that the access and and ecosystems are being destroyed at the rate of over intellectual property issues related to “terminator gene” 100 million ha every year.

More than 31 000 plant and technologies will lead to increasing dependence on animal species are threatened with extinction; according industrialized nations by African countries, and to the Food and Agriculture Organization of the UN, at domination of world food production by a few least one breed of livestock dies out every week.
Band- multinational companies.

aids are not enough: only a fundamental and far-reaching Biopiracy is also of growing concern, particularly as solution can ensure a biologically rich world for future many African countries lack the legislative and generations” (CBD and UNEP 2003).

enforcement systems to control illegal extraction of The range of actors involved in policy development genetic resources.

Additionally, the benefit sharing has increased dramatically.
Governments, scientists, systems for the use of these assets and of traditional the private sector and civil society have all become knowledge are poorly developed.

active players.

The extent to which the concerns and The issues of proprietary science have complicated interests of these respective groups are acknowledged the ethical and safety issues of GM technology.

In varies between countries and across issues.


However, particular there are challenges around reconciling the as Box 7 shows, given the complexity of the issues and rights of product developers with those of consumers.
the risks associated with them, a growing number of Many public protests have centred on ethical or policymakers, at the national, regional and global ecological grounds, the uncertainty about the impacts levels, are acknowledging the importance of inclusive of the technology, and the public right-to-know and to policy processes.

Box 8 looks at one initiative that have access to information, including through labelling.
In several countries, concerns have been raised as to whether “the technology is tantamount to playing god, interfering with nature, contrary to local ethics and also Box 7: Doing the right thing is not simple whether gene insertion would play havoc with the totem Governments cannot achieve biosafety on their own; system that lies at the heart of local cultural they need the active involvement and cooperation of association” (Mohamed-Katerere 2003).
other stakeholders: RESPONSES ● Agricultural and health-care research institutes and the biotechnology industry can play a particularly important role.

Biotechnology researchers and companies have the expertise, the resources and the incentive for keeping biotechnology and its products There are a wide range of responses, at multiple levels, safe and beneficial.

to the growing challenges posed by the development of ● Civil society, individual citizens and non- GM technologies and products.
These include global governmental organizations need to understand the and regional intergovernmental responses, science- issues and make their views clear to both based responses and civil society initiatives.

As a policymakers and industry.

whole, the overall approach of African governments ● The media have a vital watchdog role to play.
has been to encourage a range of biotechnology research (both transgenic and non-transgenic) while Because biotechnology is such a revolutionary science, recognizing biosafety concerns and establishing and has spawned such a powerful industry, it has great systems to limit its impact.

potential to reshape the world around us.

It is already Biosafety approaches have been shaped by the changing agriculture and what many of us eat.
Any worldwide acknowledgement of the growing threats major mistakes could lead to tragic and perhaps which ecosystems and biodiversity face from human permanent changes in the natural world.

For these activity, and the long-term implications this has for reasons, future generations are likely to look back to our development and human well-being.

The CBD time and either thank us or curse us for what we do – or secretariat along with UNEP for example notes: don’t do – about GMOs and biosafety.
“The stakes are high: although some 40% of the world economy is derived directly from biological diversity, Doing the right thing is not simple.

humanity is pushing ecosystems, species and gene pools to extinction faster than at any time since the dinosaurs Source: CBD and UNEP 2003 died out 65 million years ago.
At present, natural habitats SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 317 Box 8: The African Biotechnology Stakeholders Forum The African Biotechnology Stakeholders Forum (ABSF) is strengthening its application for increased food a not-for-profit and non-sectarian organization funded by security, health improvement, poverty alleviation, the United States Agency for International Development industrialization and environmental conservation (USAID).
It provides a platform for sharing, debating, and in Africa.

understanding issues pertaining to biotechnology in ● Improve public understanding of biotechnology agriculture, health, industry and the environment.

The through provision of accurate and balanced African Biotechnology Stakeholders Forum represents information to consumers, media and policymakers stakeholders in biotechnology in Africa.
It currently has to ensure that biotechnology is accurately individual members in Kenya, Uganda, Tanzania, Ethiopia, represented at all levels of society.

South Africa, Ghana and Nigeria; small and medium sized ● Explore innovative and appropriate biotechnology enterprises involved in research, development, testing and applications and facilitate their adoption and use commercialization of biotechnology in Tanzania, Ethiopia, in sustainable development and poverty alleviation Uganda and Ghana.
Through its membership and in Africa.

linkages, ABSF is a voice for many biotechnology ● Build capacity for information generation, stakeholders, including farmers, scientists, consumers, dissemination and wise use of biotechnology.

politicians and government bodies.


● Facilitate research, development, education and The ABSF objectives are to: training on biotechnology as well as policy and ● Provide a forum for sharing and exchanging experiences infrastructure development for meeting Africa’s needs in and practices in biotechnology with a view to biotechnology.

Source: ABSF undated brings together stakeholders at the regional level.

from economic cost-benefit type analysis.


In general, Annex 3, Table 1 shows some of the national, sub- they adopt narrow technical approaches, which focus regional and regional organizations active in on the characteristics of the host organism and the biotechnology issues.

SCIENCE-BASED RISK ANALYSIS Risk analysis is concerned with how to evaluate, resulting GMO, the expression and properties of the gene product and the biophysical features of the recipient environment (Mohamed-Katerere 2003).
These approaches and their general principles have contain or avoid negative impacts resulting from the been developed over several decades in response to uncertain behaviour of GM products and processes.

To technological development in the chemical and be effective, such assessments need to address all pharmaceutical industries.

These standardized costs-and-benefits, and not be restricted to financial approaches are particularly attractive to companies expenditures and profits (Young 2004).
It needs to and governments as they are simplified and avoid the address direct and indirect costs-and-benefits, as well costs of case-by-case analysis.

as opportunity costs, such as the impact on Two factors underlie the analysis of risk environmental goods-and-services as well as on (Young 2004): agricultural and social systems.
Field trials and how ● The magnitude of each potential harm or benefit crops behave in conditions similar to those following that might occur; and actual release are a critical step in the assessment ● The likelihood of its occurrence.

process, allowing product developers to address problems arising.
They play an important role in Magnitude is particularly important from a human and identifying risks and creating an opportunity for environmental perspective; certain kinds of changes, mitigation and adaptation prior to full release.

such as biodiversity loss, may be irreversible.

However, the standardized approach to risk Magnitude is difficult to ascertain where there is assessment does not allow for such levels of insufficient experience with a product or activity.

complexity.
complexity.

Most national risk analysis frameworks Likelihood is based on comparison with similar focus on risk-benefit assessments that are derived situations in the past.

318 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH SUBSTANTIAL EQUIVALENCE AND FAMILIARITY In the area of GM crops, many national assessment risks posed by this technology are fundamentally different from those posed by earlier agricultural systems are based on the concepts of “substantial technologies.
The range of uncertainties is greater than equivalence” and “familiarity” to determine the ever before and includes fundamental scientific likelihood of potential harm (Scoones 2002) and to uncertainties and ignorance about the potential decide on further product testing and development as environmental and health risks, as well as wider well as commercial release.

In general, it neglects the uncertainties about the impact on agricultural systems socioeconomic aspects.
and rural livelihoods (Scoones 2002).

The importance The concept of familiarity has been used in the of recognizing uncertainties and ignorance is evident chemical industry to determine safety levels on the from the Bovine Spongiform Encephalopathy (BSE) assumption that closely related chemicals will behave in crisis, or mad cow disease, which resulted in major the same way.

This approach is now used in GM risk economic and health costs in the UK and Europe.

assessment.
assessment.

Such models have a high level of appeal Classical assessment approaches which treat scientific because they do not require regulators to deal with aspects separately from ethical, moral, social and complex and case-specific factors.

This framework economic considerations may be inappropriate and neglects the issue of magnitude and rare but significant have been widely criticized over many years (Scoones impacts.

It may not be as well suited to LMO as these 2002).
In this context of uncertainty, other approaches, can behave in unpredictable ways.

including the precautionary approach, can be a Substantive equivalence between organisms is used valuable part of risk assessment.

Taking a precautionary as an indication of how they will behave.

The concept approach requires acknowledging the potential for was originally developed as a way for determining food unforeseen consequences, complex effects and safety (Scoones 2002).
If a new GM product is ignorance (Scoones 2002).

The precautionary substantially equivalent in chemical composition to its approach offers the opportunity to address normative natural antecedent then it is assumed to be safe.

This values of justice, fairness and responsibility which approach neglects the uncertainties around the actual classical risk assessment does not do (Mohamed- modification of DNA.

Katerere 2003).
Katerere 2003).

A further challenge for risk assessment processes is INTEGRATIVE APPROACHES Risk is different from cost because, on the one hand, a that the range of actors in the development of new policy making and the negotiation process of regulatory and certain level of risk is necessary for social, political and policy frameworks is wider than ever before: it includes economic advancement and, on the other, risk is by its global institutions, multinational companies, NGOs, nature uncertain.
The challenge in the area of GM is that governments and intergovernmental bodies, scientists 25-29 January 2006.

A “citizens’ jury” – 43 small and medium-size farmers – meets in Mali to hear evidence from 14 international witnesses, representing a broad range of views on GM crops.

Witnesses included biotech scientists, FAO, and GM farmers from South Africa and India.
The jury decided against introducing GM crops and instead made recommendations to strengthen traditional agricultural practice and support local farmers.

Source: M. Pimbert SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 319 and farmers acting at and across national, regional and global levels.

This highlights the need for deliberative participatory processes over simple consultation.
Participation is successful when it promotes responsiveness to local and national needs, legitimacy and “ownership” of policy and law.

Thus, the processes for participation need to be appropriate and relevant to the country concerned (Glover 2003b).

Many African countries have recognized this: participatory approaches have been used in policy development in relation to national law and policy development.
Current risk assessment processes are closely allied to globalization in which individual (R&D, economic and propriety) rights trump social and cultural rights and concerns; these issues are assumed to be adequately addressed through the market and consumer choice Bacillus thuringiensis.

(Mohamed-Katerere 2003).


Source:University of Georgia A range of approaches that deal with such complex decision making have been developed which recognize the plurality of views as well as a level of uncertainty and The AU’s Comprehensive Africa Agriculture ignorance.

These include quantitative approaches Development Programme (CAADP) promotes an designed to examine the multicriteria important in integrated multilevel response to the challenges of decision making, scenario approaches which agriculture.
This framework should serve as the basis for systematically analyse future options, and deliberative developing agricultural strategies.

As the Millennium participatory approaches; these approaches introduce Task Force on Science and Technology cautions, rigour not by limiting the issues under consideration but technology cannot of itself determine social change but by being transparent and addressing the full complexity it can be a useful tool when aligned with development of the issues (Scoones 2002).
goals and when supporting governance structures are created (UN Millennium Project 2005b).

LEGAL AND POLICY RESPONSES The introduction of GMOs has brought new challenges for authorities and policymakers who have to consider CARTAGENA PROTOCOL At a global level, the key response to concerns about impacts on human health, poverty and hunger, biosafety is the Cartagena Protocol on Biosafety livelihoods and food security, free trade and adopted in 2000 under the CBD of 1992.
The Protocol international markets, and the environment, is primarily concerned with transboundary movement particularly biodiversity.

Laws and institutions need to of LMOs; it provides a framework for countries to assess ensure that an acceptable trade-off between competing risks associated with LMO prior to authorizing and often conflicting interests is maintained.

As GMO importation.
As GMO importation.

It seeks to ensure: technology is relatively new, governance systems are also in their infancy and have not been able to take all “An adequate level of protection in the field of these challenges on board.

the safe transfer, handling and use of living Africa is responding to these challenges at multiple modified organisms resulting from modern levels.
It has supported initiatives at the global level biotechnology that may have adverse effects such as the CBD and its Cartagena Protocol.
It has on the conservation and sustainable use of developed cutting-edge solutions at the regional level biological diversity, taking also into account such as the African Union’s (AU) Model Law on Safety in risks to human health, and specifically Biotechnology (African Biosafety Model Law) and has focusing on transboundary movements” begun to develop national frameworks for GMO (Secretariat of the CBD 2000).

development and biosafety.


The AU has also adopted a Model Law for the Protection of the Rights of Local Two key concepts, biosafety and precaution, form the Communities, Farmers, Breeders and Regulation of basis for the framework developed in the Protocol.

Access to Biological Resources.

Biosafety is based on the concept of precaution and 320 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Box 9: Precaution Principle 15 of the Rio Declaration provides that: Box 10.
The Cartagena Protocol applies the precautionary approach to biodiversity and to human risks.

It gives importing countries the right to take socioeconomic considerations into account, as long as “Where there are threats of serious or irreversible damage, lack of full these are consistent with their international obligations.
scientific certainty shall not be used as a reason for postponing cost- The Protocol allows governments on the basis of effective measures to prevent environmental degradation.” precaution to prohibit the import of a GMO, even where there is insufficient scientific evidence about potential The Cartagena Protocol applies precaution not just to biodiversity, but to potential adverse effects (CBD and UNEP 2003).

risks to human health as well.


Additionally it gives importing countries the right The Protocol entered into force in July 2003. to take into account socioeconomic concerns (provided their actions are Although the Protocol has been signed by 37 African “consistent with their international obligations”).
Such concerns could include the countries, many of these have not yet ratified it or risk that imports of genetically engineered foods may replace traditional crops, developed laws to incorporate it into their legal undermine local cultures and traditions or reduce the value of biodiversity to framework (CBD 2006): Algeria, Benin, Botswana, indigenous communities.
Source: Secretariat of the CBD 2000, UN 1992, CBD and UNEP 2003 Burkina Faso, Cameroon, Cape Verde, Democratic Republic of the Congo, Djibouti, Egypt, Eritrea, Ethiopia, Gambia, Ghana, Kenya, Lesotho, Liberia, Libya, Madagascar, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Seychelles, South Africa, Sudan, Swaziland, implies minimizing the risk to human, animal and Togo, Tunisia, Uganda, Tanzania, Zambia, and environment health (see Box 9).
It includes a range of Zimbabwe.

Table 2 shows the status of the Cartagena measures, policies and procedures to minimize Protocol in African countries.

potential risks.

The precautionary approach has been African countries are faced with the challenge of specifically incorporated in the Protocol.

dealing with transboundary movement of GMOs and Although there remains much controversy about illegal use or research activities.
Some African country what exactly constitutes a precautionary approach, borders are porous, difficult to police and at times there is evidence of wide support for it as reflected in subject to bribery (GMWatch 2005).
GM maize and rice Box 10: IUCN-The World Conservation Union calls for precaution IUCN is a global union of governments, civil society for “a moratorium on further environmental releases of organizations (CSOs) and experts; it brings together 82 state GMOs until they can be demonstrated to be safe beyond members, 112 government agencies, 784 national NGOs, reasonable doubt.” It also requests the IUCN Council to: 33 affiliate members and 84 international NGOs.
● Prepare policy guidance for sustainable GMOs through Consequently it is an important global voice.

a multifaceted approach; In 2002, IUCN adopted a resolution on GMOs, which ● Promote and support initiatives to ratify the Cartagena noted the lack of knowledge of the effects on biodiversity Protocol on Biodiversity; and and on the potential role of GMOs in “achieving global ● Encourage public awareness and promote access to food security.” which it notes “has not been adequately information.
demonstrated so far.” It focuses on the need to adopt a precautionary approach to GMO as set out in Principle While the resolution was sponsored by most state and 15 of the Rio Declaration and the Cartagena Protocol on NGO-members, state members such as Japan, The Biosafety.

To this end it calls “upon key private sector Netherlands and Sweden were against the resolution.
companies to integrate biodiversity into their corporate The US government and agency members refrained social responsibilities and actions.” from the deliberations.
In 2004, IUCN, at its 3rd World Conservation Congress held in Bangkok, Thailand, passed a resolution, which calls Source: IUCN 2004 SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 321 Table 2: African countries status on Cartagena Protocol on Biosafety Country Algeria Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo Côte d’Ivoire Democratic Republic of the Congo Djibouti Egypt Equatorial Guinea Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Libya Madagascar Malawi Mali Mauritania Mauritius Morocco Mozambique Namibia Niger Nigeria Rwanda São Tomé and Príncipe Senegal Seychelles Sierra Leone Somalia South Africa Sudan Swaziland Tanzania Togo Tunisia Uganda Zambia Zimbabwe Source: CBD 2006 Signature 25 May 2000 24 May 2000 1 June 2001 24 May 2000 Ratification/accession Entry into force 5 August 2004 3 November 2004 2 March 2005 11 June 2002 4 August 2003 31 May 2005 11 September 2003 2 November 2003 9 February 2001 20 February 2003 11 September 2003 1 November 2005 30 January 2006 24 May 2000 24 May 2000 21 November 2000 23 March 2005 8 April 2002 21 June 2005 11 September 2003 20 December 2000 23 December 2003 21 March 2004 24 May 2000 24 May 2000 24 May 2000 10 March 2005 9 October 2003 8 June 2005 7 January 2004 9 June 2004 30 May 2003 7 September 2004 11 September 2003 15 May 2000 24 January 2002 11 September 2003 20 September 2001 11 September 2003 15 February 2002 14 June 2005 11 September 2003 12 September 2005 14 September 2000 24 November 2003 22 February 2004 24 May 2000 4 April 2001 25 May 2000 24 May 2000 24 May 2000 24 May 2000 24 May 2000 24 May 2000 28 August 2002 11 September 2003 22 July 2005 11 April 2002 20 October 2005 11 September 2003 21 October 2002 10 February 2005 11 September 2003 11 May 2005 30 September 2004 29 December 2004 15 July 2003 22 July 2004 13 October 2003 20 October 2004 31 October 2000 8 October 2003 23 January 2001 13 May 2004 6 January 2004 11 August 2004 14 August 2003 13 June 2005 13 January 2006 24 April 2003 2 July 2004 22 January 2003 12 November 2003 11 September 2005 13 April 2006 11 September 2003 30 September 2004 11 September 2003 30 November 2001 11 September 2003 24 May 2000 19 April 2001 24 May 2000 4 June 2001 25 February 2005 27 April 2004 25 July 2004 26 May 2005 322 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH are already being planted illegally in various regions of This model law emanated from a highly participatory Tanzania (Balile 2005).
Adoption and ratification of the process which included researchers, governments, and Protocol could be a useful option.

In the absence of civil society groups.

It reflects a broad consensus on effective monitoring and enforcement, bans on the issues of biotechnology development.

The regulatory import of GM seeds are of no effect (Balile 2005).
The framework utilizes the discretion given by the Cartagena shipment of grain requires leak-proof containers to Protocol on Biosafety for countries to adopt more avoid unintended GMO product contamination.

stringent protective measures than the agreed Therefore, responsible deployment of GM crops needs minimum set out in the Protocol.
The African Biosafety to encompass the whole technology development Model Law recognizes the importance of Africa as a process, from the pre-release risk assessment, to centre of origin and a centre of diversity with regard to biosafety considerations, to post-release monitoring food and other crops.

It makes provision for considering (FAO 2005).

Monitoring GM crops will provide socioeconomic factors in assessing risks and information for policies and regulations; it will give opportunities.
Key legal principles and approaches producers and policymakers better information to help incorporated include: them develop safer adoption processes.

● Precautionary; REGIONAL RESPONSES The African Biosafety Model Law was adopted by the rigorous risk assessment of any GMO for any use before any decision regarding the GMO is made; and ● The sovereign right of every country to require a AU at its 74th Ordinary Session in Lusaka, Zambia, in ● A liability and redress regime.
July 2001, and urged member states to use the African Biosafety Model Law to draft their own The African Biosafety Model Law provides a holistic and national legal instruments.

comprehensive set of biosafety rules including issues that are not dealt with by the Biosafety Protocol.
These include mandatory labelling and identification or traceability requirements for GMOs and GM food, and liability and redress for harm caused by GMOs to human health and the environment, and for resultant economic loss (Mayet 2003).
SUB-REGIONAL APPROACHES Six regional economic communities in Africa, namely the Economic Commission of West African States (ECOWAS), the East African Community (EAC), the Economic Community of Central African States (ECCAS), the Intergovernmental Authority on Development (IGAD), the Southern African Development Community (SADC) and the Arab Mahgreb Union (AMU) have taken the lead in developing policy guidance on GMO research, production and marketing in their respective regions.
In Kampala, in November 2002, agricultural ministers of the Common Market for Eastern and Southern Africa (COMESA), agreed to create a regional policy on GMOs.

Similarly, the SADC established an advisory committee on GMOs to develop guidelines and to assist member states in guarding against potential risks in food safety, contamination of genetic resources, ethical issues, trade- related issues and consumer concerns.

These are set out in Box 11.


The EAC has recommended reviewing and developing a common policy on GMOs.

The IGAD The seed bank at the KwaNgwanase Farmers’ Association nursery in northern KwaZulu-Natal.
members formed a Verification and Monitoring Team Source: Biowatch (VMT) to ensure that food assistance be certified as free SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 323 Box 11: SADC recommendations on genetically modified organisms The following recommendations were formulated by the SADC Advisory ● All member states should sign and ratify the Cartagena Protocol on Committee on Biotechnology and Biosafety and were approved by the Biosafety to the CBD.
SADC in August 2003 as interim measures aimed at guiding the region ● The region should develop a harmonised policy and regulatory on issues relating to biotechnology and biosafety.

systems based on the African Biosafety Model Law and the Cartagena Protocol on Biosafety and other relevant international Handling of food aid processes.
● The Southern African Development Community should develop and ● Member states without a regulatory framework for GM crops should adopt a harmonized transit information and management system for use approved guidelines and should not import genetically modified GM food aid designed to facilitate transboundary movement in a grain for seed before approved guidelines are in place.

safe and expeditious manner.


● Risk assessments should be done on a case-by-case basis and ● The Southern African Development Community is encouraged to every genetic modification should be tested in the environment source food aid preferably from within the region, and advise all under which it will be released.

cooperating partners accordingly.


● Donors providing GM food aid should comply with the Prior Capacity-building Informed Consent principle and with the notification requirements in ● Member states should develop capacities at national and regional accordance with Article 11 of the Cartagena Protocol on Biosafety.

levels in order to develop and exploit the benefits of biotechnology.
● Food aid consignments involving grain or any propagative plant ● The Southern African Development Community should allocate material that may contain GMOs should be milled or sterilized prior resources for capacity-building in management of biotechnology to distribution to the beneficiary population.

and biosafety.

● Food aid in transit that may contain GMOs should be clearly ● The Southern African Development Community should encourage identified and labelled in accordance with national legislation.
member states to commission studies on the implications of ● Southern African Development Community countries managing or biotechnology and biosafety on agriculture, environment, health handling food aid in transit that may contain GMOs are encouraged in and socioeconomics as part of an integrated monitoring and the absence of national legislation to make use of the requirements evaluation system.
under the African Biosafety Model Law and/or the South African Guidelines on the handling of transit material which may be GM.

Public awareness and participation Policy and regulations programmes on biotechnology and biosafety that involve all ● Each member state should develop national biotechnology policies stakeholders.

● Member states should develop public awareness and participatory and strategies and expedite the process of establishing national biosafety regulatory systems.
Sources: SADC 2004 of GMOs.

Fifteen members of ECOWAS attended a Biological Resources.

Other region-wide organizations meeting to better understand and discuss the benefits such as New Partnership for Africa’s Development and threats of GMOs.

(NEPAD), and its Science and Technology Secretariat could have an important role.
NATIONAL POLICY AND LAW The need for adequate national policies and laws to At least nine countries have biosafety legislation or guidelines including Benin, Cameroon, Malawi, regulate biotechnology research and establish effective Mauritius, South Africa, Tanzania, Uganda, Zambia, and assessment processes which safeguard human and Zimbabwe.

Ghana, Kenya, Lesotho and Swaziland all environmental health is widely acknowledged.
There is have draft legislation that addressees the issue of a need to develop harmonized approaches to biosafety, the commercialization of GM crops and the biotechnology and the African Biosafety Model Law importation of GM foods.
provides a good basis for this, as does the Model Law Developed country aid agencies and international for the Protection of the Rights of Local Communities, organizations have had a keen interest in supporting the Farmers, Breeders and Regulation of Access to development of an enabling legal environment for 324 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH transgenic research and biosafety.

Some of these initiatives appear in Annex 3 Table 2.
The United States INCLUSIVE POLICY PROCESSES Inclusive policy processes, based on adequate Agency for International Development is the most information, are essential to developing appropriate active in this area.

The US has been a keen supporter of national and regional responses.

The potential risks and GM crop development, offering it as food aid, and the opportunities posed by GM technologies are immense.

US is also the largest producer of GM crops.


Several Decision making is a process of accountability – to African countries have or are in the process of one’s constituency, one’s country and the world – and developing biosafety policies and law through a United as such it must necessarily be based on a weighing of Nations Environment Programme (UNEP) – Global evidence, not only evidence that a decision might pose Environmental Facility (GEF) initiative.
This capacity- a particular risk or benefit, but also evidence about the building project supported 100 developing countries to potential dimensions of that risk or benefit, about the prepare national biosafety frameworks.

Thirty-six likelihood of harm or advantage, about the efficacy of African countries have or are participating in this available measures to prevent or mitigate risks, and project.
An AU biosafety capacity-building project about other factors and situations within and outside designed to spearhead the harmonization of biosafety the decision-maker’s jurisdiction that affect the decision legislation between member states based on the (Young 2004).

Thus it is crucial for decision-makers, African Biosafety Model Law has been developed.

legislators, governments and the civil society, to have THE WAY FORWARD: OPPORTUNITIES AND CONSTRAINTS access to adequate supporting information.
Given the complexity of the issues at stake from biosafety considerations, human health concerns and socioeconomic implications, it is essential that policy processes use a range of techniques that are able to support effective valuation in these areas.
Africa’s experience with GM technologies is still relatively In it is also important, given the range of interests at new compared to other regions and it is faced with many stake, that policy processes become more deliberative, challenges on how best to proceed.

Knowledge, transparent and accountable.

transparency, fairness and containment are four key points in formulating a sound African policy on GMOs.

Cotton weaving in Essaouira, Morocco.


Cotton is an important part of livelihoods in many African countries.

Source: J.C. Mohamed-Katerere WEIGHING THE CHOICE OF AGRICULTURAL OPTIONS A crucial issue facing African governments is determining what kind of development and agricultural strategies can best meet long-term objectives and medium- to short-term goals.
A viable agricultural strategy should contribute to the realization of the MDGs and targets including: ● Eradicating extreme poverty and hunger; ● Ensuring environmental sustainability; ● Reducing child mortality; ● Improving maternal health; and ● Combating HIV/AIDS, malaria and other diseases.

Defining such a strategy and identifying appropriate solutions is dependent on research that accurately understands the nature of the problem.
Declining African agricultural research has meant that, increasingly, research priorities are often externally driven on the basis of assumptions that are not shared.

Much global agricultural research is based on models which focus on production deficits and fails to take into account the multiple factors that are driving food crises including globalization, environmental degradation and HIV/AIDS.
The opportunities of and challenges faced by agricultural SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 325 production systems are discussed in Chapter 3: Land and Chapter 4: Freshwater.
The problems of food security are Box 12: Developing sustainable agricultural production systems complex and can probably not be resolved through a The Millennium Project Task Force on the Environment identified the following as “technological fix.” Instead they require multisectoral and critical to enhancing sustainable agriculture techniques to preserve natural assets: multilevel (local, national, international) interventions.

● Protect and improve soils, including enhanced carbon sequestration.
Nevertheless, GM technologies offer promise for meeting ● Use water sustainably.

some areas of greatest challenge in Africa.

Benefits to the ● Maintain crop genetic diversity.

environment can be summarized to include: “friendly” ● Mobilize local knowledge and experience.

bioherbicides and bio-insecticides, and conservation of ● Improve crop research, management storage, and use.

soil, water, and energy.

Increased food security for the ● Restore and manage desertified lands.
growing populations may result from GM enhanced crop ● Adopt prevention strategies to protect arid ecosystems.

and livestock productivity.

● Mobilize information and technology.

New GM technological advances may create ● Protect surrounding natural habitat.

ethical controversies around tampering with nature, ● Rationalize land-use planning.

from, for example, mixing genes among species and ● Set up systems of communal ownership and management rights.
related objections to consuming animal genes in plants and vice versa.

Source: UN Millennium Project 2005a Like all new technologies, they also pose some risks, both known and unknown.

Potential environmental impacts include: unintended transfer of transgenes through cross-pollination, unknown effects on other farmers’ rights.

In addition to directly protecting farmers’ organisms (eg soil microbes) and loss of flora and fauna rights, measures to protect genetic resources and ensure biodiversity.
Traditional agricultural systems have benefit sharing may be valuable.

These may include: played an important role in maintaining crop diversity.

● Fair and equitable allocation of profits to local Certain human health impacts have been identified.

The communities from which genetic material was impacts on livelihoods, food security and rural options obtained; are not well understood.
● Adhering to local law and respecting and protecting Although genetic engineering may offer important local cultures and resources; and opportunities for development and achieving the ● Adhering to the CBD, particularly Article 8J, and the MDGs, it is important to strengthen existing local International Labour Organization (ILO) Convention production systems and not compromise the existing No.

169 Concerning Indigenous and Tribal Peoples systems.
Clear cost-benefit analysis about the efficacy in Independent Countries.

of different kinds of technological options need to be undertaken alongside locally-driven priority-setting In 1998, the Council of Ministers of the AU adopted the exercises.

The question remains as to whether Model Law for the Protection of the Rights of Local development of genetic engineering is a priority for Communities, Farmers, Breeders and Regulation of African governments at this point in time.
Access to Biological Resources.

This serves as a basis The value of existing agricultural approaches and for African countries to develop national law which non-transgenic approaches for Africa need to be fulfils their obligations to TRIPS and to the CBD, while considered.

Achievements that have been made, protecting the collective social process of knowledge including improving yields, better management of and technology generation.

insects.
insects.

pests, plant diseases and weeds without the use of synthetic pesticides, and the maintenance of soil fertility without chemical fertilizers (ERA 2005), should BIOSAFETY AND RISK ASSESSMENT A biosafety approach would include taking measures to be consolidated.

The value and productivity of minimize risks to human and environmental health.

This traditional agriculture in development and its genetic could include: diversity should not be underestimated.
Africa has ● Ensuring that thorough information is available and more than 2 000 native grains, roots, fruits and other that risks are understood and mitigated; food plants (National Research Council 1996).
● Products containing GMOs must be clearly labelled The issue of IPRs will need to be addressed to ensure and information readily available; that there are no adverse consequences for food ● Clear and fair liability laws and producer productivity, through, for example, the weakening of responsibility; and 326 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH ● Genetic and biological material should be managed and contained to high standards.
RESEARCH PRIORITY-SETTING Agricultural research, including transgenic research, needs to focus on African realities and needs.

African Evidence-based GMO risk assessments to assure agriculture is largely small-scale and relies on poly- transparent decision making based on human health and cultures, which consists of many crops being grown on ecological data need to be developed.
Risk assessments the same plot with possibilities of symbiotic leguminous should be on a case-by-case basis as results obtained relationships providing nitrogen fixation (Makanya from other countries might not be replicable.

Deliberative 2004).

In addition to intercropping, trees and shrubs approaches should be considered.
(agroforestry) are the anchor perennial species, providing The controversy around risks and opportunities mycorrhiza for mobilizing phosphorus and other demonstrates the need for effective multilevel nutrients.

and these trees and shrubs promote soil assessment procedures that incorporate a protection against erosion by wind and water.

Also, each precautionary approach as envisaged under the of Africa’s main staples and about 300 leafy vegetables Cartagena Protocol.
This policy and legislative have perennial cultivars and provide a starting point for approach needs to be complemented by capacity the genetic selection and breeding of the best cultivars to development.

Countries need to have the capacity to incorporate into the traditional tree-and-shrub poly- identify GMOs and also to evaluate the risks associated culture in farming households (Odhiambo 2001).

with them.
with them.

RISK MANAGEMENT Possible mitigation plans should be in place in case Development of GMOs should aim to tap these special qualities of Africa’s native flora and fauna in the efforts to improve food security and make genetic engineering beneficial to Africa’s environment and development.

undesirable outcomes are experienced.


This requires Research will need to be based on meaningful that African countries should establish efficient partnerships between users and researchers if it is to traceability systems as part of their mitigation measures.

be more responsive to local needs (Jones 2005).

Given Genetic engineering, Egypt.

Agriculture project researching into GM foods.


Source: J. Schytte/Still Pictures SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 327 Box 13: Biotechnology for smallholder farmers that it supports them in achieving their development objectives.
They can address concerns about Biotechnology research that is appropriate for domination of world food production by, for example, smallholder farming includes biotechnologies which: excluding plants and animals from patent protection.

● are affordable; Farmers can be protected by explicitly allowing them to ● do not restrict or prohibit farmers from saving and save, re-use and exchange harvested seed.
There may exchanging seed; be a need to engage and negotiate with multinational ● are responsive to local livelihood contexts; corporations through their global federations (such as ● are appropriate to patterns of labour availability; Crop Life International).
Lessons can be learnt from the ● are suitable for use in a multicrop system; experience of countries such as India which have ● have traits such as increased drought tolerance, succeeded in attracting investment in this area while at nutrient-use efficiency and disease resistance; the same time protecting the interests of small farmers.

● are suitable and safe for the local ecosystem; and ● are backed by appropriate support, including access to credit, markets and extension services.
Source: Glover 2003a CAPACITY-BUILDING Building capacity in biosafety is a broad task.

It includes training individuals in the scientific, legal and policy aspects of risk assessment as well as enhancing research capacity.

There needs to be capacity-building of existing institutional talent and establishment of sound research, development, and extension, the multiplicity of CSOs and other public interest marketing and monitoring units.

Efforts to foster groups.


there is considerable opportunity for cooperation and scientific advisory committees at sub- developing such partnerships.

regional levels are encouraged.

Partnerships with the private sector are essential for Agricultural research throughout Africa has yielded the sharing of technologies, information and knowledge.

high returns financially and improved livelihoods.


SOUND LEGAL AND POLICY FRAMEWORK A sound legal and policy framework for assessing risks However, today agricultural research is under threat from decreasing capacity as a result of inadequate government investment and a series of externally and benefits, regulating research, monitoring research imposed conditionalities (Scoones 2005).
Privately- and commercialization, as well as protecting rights, is driven R&D has been unable to fill this gap and it is crucial essential.

There needs to be complementarity between that Africans increase investment in research systems.

the various levels of law and policy, from the global to Partnership is central to building capacity in R&D.
The the local, as well as across different sectors (eg application of modern biotechnology to agricultural agriculture and technology) and different sets of rights research systems across the developing world calls for (eg IPRs and farmers’ rights).

new investments, changes in resource allocations and Legal frameworks need to recognize key legal new responsibilities for policymakers, research managers principles and rights that are applicable to the and scientists alike.
Improving research capacity through development and application of GM technologies.

developing partnerships, to solve local problems, with These include precaution; rights to participation and institutions that have advanced technologies, human access to information; rights to development as well as resources, laboratory infrastructure and funds for routine a safe and healthy environment; IPRs, indigenous administrative work are necessary.
African countries knowledge and farmers’ rights; and issues of legal might benefit from the pooling of resources for R&D of responsibility.

Useful measures that can support an GMO technologies.

Where patentable products are effective legal framework could include labelling and developed, there will be a need for serious consideration risk assessment and management.

For traceability of on the subsequent equitable utilization of the accrued GM products, country of origin labelling should be fully income.
African countries need to increase their own enforced also for the purposes of record-keeping and investment in capacity-building.

informing the public who can then make a choice The application of biosafety principles serves to whether or not to use the products.

minimize the risks of GM technologies.


Agenda 21, and Although, under WTO agreements, countries need to the CBD and its Cartagena Protocol on Biosafety (2000) adopt IPR legislation, in doing so they have a fair are international instruments that address biosafety amount of latitude.

They need to tailor IPR legislation so issues.


Many African nations do not have the capacity 328 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH to implement this protocol; they lack capacity in terms of expertise, equipment, infrastructure, legislation and regulatory systems (Diouf 2001).

Capacity needs to be built to enable African countries to engage more effectively in global policy fora so that multilateral instruments do not compromise Africa’s interests.
CONCLUSION Developing a sustainable agricultural strategy that ensures food security, does not threaten the environment or biodiversity, and promotes human well- being must be a priority for Africa.

Africa is faced with the decision of whether GM crops can be part of this, and if so, how to manage the risks and uncertainties associated with GM technology.
In evaluating the options, Africa needs to consider the potential benefits from possible yield gains and a decrease in the need for chemical use against the threats posed to biodiversity, livelihoods and cultural systems.

References ABSF (undated).About ABSF.African Biotechnology Stakeholders Forum.

http://www.absfafrica.org/php/about_absf.htm Aerni, P. (2005).

Mobilizing Science and Technology for Development: The Case of the Cassava Biotechnology Network (CBN).
Proceedings of the 9th ICABR International Conference on Agricultural Biotechnology: Ten years later.

Ravello, Italy, 6-10 July.

http://www.economia.uniroma 2.it/conferenze/icabr2005/papers/Aerni_paper.pdf African Centre for Biosafety (2005).

GMOs in African Agriculture – Country Status: Southern Africa.

http://www.biosafetyafrica.net/ south.htm Altieri, M.A.

(2002).The Case Against Agricultural Biotechnology:Why Are Transgenic Crops Incompatible With Sustainable Agriculture In The Third World?
Sustainable Agriculture/Final draft/Panel 2/July 2002. http://www.iucn.org/themes/ceesp/Publications/SL/Miguel%20A.%20 Altieri%20Biotec%20Third%20World2.pdf Altieri, M.A.

and Rosset, P. (1999).Ten Reasons Why Biotechnology Will Not Help the Developing World.

AgBioForum.

2 (3 & 4), 155-62. http://www.iucn.org/themes/ceesp/Publications/SL/Miguel%20A.%20Ati eri%20%20and%20Peter%20Rosset-%2010%20Reasons%20Why%20 %20Biotech%20Will%20Not%20Ensure%20%20Food%20Security.pdf Apps, P. (2005).
South Africa leads on GMO, other African states wary.

Reuters News Service, 1 March.

http://www.planetark.com/ dailynewsstory.cfm/newsid/29768/story.htm Australian Broadcasting Corporation (2001).

Pests resistant to cotton.

ABC Regional National News, 19 April.

http://www.abc.net.au/rural/ news/stories/s279777.htm Balile, D. (2005).

Minister says Tanzania is growing GM tobacco.

Science and Development Network News, 22 April.


http://www.scidev.net/content/news/eng/minister-says-tanzania-is- growing-gm-tobacco.cfm Bernsten, R.H. (2004).Week 4: How can LDCs increase food production?

F-2004.

http://www.msu.edu/course/eep/260/Fall2004/ Lectures/WEEK_04.04.WithPhotos.pdf Brown, P. and Gow, D. (2005).

Damning verdict on GM crop.

The Guardian.

March 22. http://education.guardian.co.uk/higher/ research/story/0,,1443313,00.html CBD (2006).
Cartagena Protocol on Biosafety (Montreal, 29 January 2000) – Status of Ratification and Entry into Force.

http://www.biodiv.org/biosafety/signinglist.aspx?sts=rtf&ord=dt CBD and UNEP (2003).

Biosafety and the Environment:An introduction to the Cartagena Protocol on Biosafety.

Convention on Biological Diversity and the United Nations Environment Programme.

http://www.biodiv.org/doc/press/presskits/bs/cpbs-unep-cbd-en.pdf CI (2005).
Comments on Proposed Draft Guidelines for the Labelling of Food and Food Ingredients Obtained through Certain Techniques of Genetic Modification / Genetic Engineering: Labelling Provisions (At Step 3 of the Procedure) March, 2005.

Consumers International.

http://www.consumersinternational.org/shared_asp_files/uploadedfil es/A15E8C64-0BE3-480E-BD7B-1331A22B90D5_CIstatement.doc Cox, C. (1995).

Glyphosate, Part 1:Toxicology.

Journal of Pesticide Reform.

15 (3).


http://www.panna.org/resources/pestis/PESTIS.1996.

16.html Cullen, D. (2004).

Major UK study sees little harm in GMO crops.

Reuters News Service, 30 November.

http://www.planetark.com/ dailynewsstory.cfm/newsid/28341/story.htm Department of Health (undated).

Understanding GMOs.

Department of Health, South Africa.

http://www.doh.gov.za/department/foodcontrol/ gmo/brochure.html Diouf, J.

(2001).
(2001).

FAO – From the Office of the Director General:Address by the Director-General of FAO to The Royal Swedish Academy of Agriculture and Forestry International Conference, Stockholm, Sweden, 14-15 May 2001: Genetically Modified Crops - Why?

Why not?

http://www.fao.org/dg/2001/GMO-e.htm EC (2005) Food and Feed Safety.

European Commission, DG Health and Consumer Protection.

http://europa.eu.int/comm/food/food/ biotechnology/etiquetage/index_en.htm ERA (2005).
Genetically Modified Crops:The African Challenge.

Environmental Rights Action (Friends of the Earth, Nigeria).

http://www.eraction.org/modules/Publications/docs/eragmoreport.pdf FAO (2005).Annex 3: Special Note From The Experts Who Participated In The Consultation.

In Genetically modified organisms in crop production and their effects on the environment: methodologies for monitoring and the way ahead.

Report of the Expert Consultation, 18-20 January.


Food and Agriculture Organization of the United Nations, Rome.

http://www.fao.org/docrep/008/ae738e/ae738e14.htm FAO (2002).

Prospects by major sector.

In World Agriculture:Towards 2015/2030: Summary Report, pp.

32-74.

Food and Agriculture Organization of the United Nations.

ftp://ftp.fao.org/docrep/fao/004/ y3557e/y3557e04.pdf FAO and WHO (2003).
FAO/WHO Expert Consultation on the Safety Assessment of Foods Derived from Genetically Modified Animals, including Fish, Rome, 17–21 November 2003 – Report.

http://www.who.int/ foodsafety/biotech/meetings/en/gmanimal_reportnov03_en.pdf SECTION 3 ● EMERGING CHALLENGES C h a p t e r 9 ● G e n e t i c a l l y M o d i f i e d C r o p s 329 Finck,A.

(1992).

Introductory Chapter: Fertilizers and their efficient use.

In World Fertilizer Use Manual (ed.Wichmann,W.).


International Fertilizer Industry Association, Paris.

http://www.fertilizer.org/ifa/ publicat/PDF/introd.pdf Fleury, J.M.

(1999).

Mountain Biodiversity at Risk.

IDRC Briefing 2. International Development Research Centre, Ottawa.

http://www.idrc.ca/es/ev-25782-201-1-DO_TOPIC.html GBDI and IITA (2000).

Report of the Global Biodiversity Institute/ International Institute of Tropical Agriculture Training Course on Biodiversity, Biotechnology, and Law.
Ibadan, Nigeria.

1-24 March.

Global Biodiversity Institute and International Institute of Tropical Agriculture.

http://www.aaas.org/international/africa/gbdi/GBDI-Ibadan.pdf Glover, D. (2003a).

Biotechnology for Africa?

Democratising Biotechnology Series: Genetically Modified Crops in Developing Countries Briefing Series, Briefing 10.

Institute of Development Studies, Brighton.

http://www.eldis.org/cache/DOC14356.pdf Glover, D. (2003b).
Public participation in National Biotechnology Policy and Biosafety Regulation.

IDS Working Paper 198.

Institute of Development Studies, Brighton.

http://www.ids.ac.uk/ids/bookshop/ wp/wp198.pdf GMWatch (2005).

Rumpus over GMO’s in Africa.

http://www.non-gm- farmers.com/news_details.asp?ID=2133 Gola, S. (2005).

Golden Rice Solution to Vitamin A Deficiency:What Lies Beneath.

http://www.eldis.org/subtemp/docs/5192/Golden%20Rice% 20solution%20to%20VAD.doc GRAIN (2005).
Field trials and commercial releases of Bt cotton around the world.

http://www.grain.org/research/btcotton.cfm?id=306 GRAIN (2004).

GM cotton set to invade West Africa:Time to act!

http://www.grain.org/briefings/?id=184 Hansen, M. (2000).

Possible Human Health Hazards of Genetically Engineered Bt Crops.

http://www.organicconsumers.org/ge/ btcomments.cfm Henao J. and Baanante C. (1999).

Nutrient Depletion in the Agricultural Soils of Africa.

2020 Brief No.
2020 Brief No.

62. http://www.ifpri.org/2020/briefs/ number62.htm IFAD (2001).

Rural Poverty Report 2001:The Challenge of Ending Rural Poverty.

International Fund for Agricultural Development, Rome.

http://www.ifad.org/poverty/index.htm ISIS (2005a).

Glyphosate Toxic & Roundup Worse.

Institute of Science in Society.

ISIS Press Release, 7 March.

Http://www.i-sis.org.uk/GTARW.php ISIS (2005b).Terminator Trees.

Institute of Science in Society.

ISIS Press Release, 1 March.


http://www.i-sis.org.uk/full/TerminatorTreesFull.php ISP (2003).The Case for a GM-free Sustainable World.Independent Science Panel.Institute of Science in Society and Third World Network,Penang.
http://www.indsp.org/A%20GM-Free%20Sustainable%20World.pdf IUCN (2004).World Conservation Congress Motions: CGR3.RES011 - A moratorium on the further release of genetically modified organisms (GMO).World Conservation Congress / Bangkok,Thailand 17–25 November 2004. http://www.trade-environment.org/output/infoxch/ CGR3.RES011.pdf Ives, C.L., Johanson,A.

and Lewis, J.

(2001).Agricultural Biotechnology: A Review of Contemporary Issues.

U.S.Agency for International Development.


http://pdf.dec.org/pdf_docs/PNACN153.pdf James, C. (2004).

Preview: Global status of commercialized Biotech/GM crops 2004.

ISAAA Briefs, No.

32. International Service for the Acquisition of Agri-Biotech Applications, Ithaca Jones, M. (2005).

Key Challenges for Technological Development and Agricultural Research in Africa.

IDS Bulletin.

36 (2), 46-51.

Institute of Development Studies, Brighton Losey, J.E., Rayor, L.S.

and Carter, M.E.
and Carter, M.E.

(1999).Transgenic pollen harms monarch larvae.

Nature, 399, 214 Mackenzie, R., Burhenne-Guilmin, F., LaVina,A G.M.

and Werksman, J.D in cooperation with Ascencio,A.

; Kinderland, J., Kumer, K. and Tapper, R. (2003).

An Explanatory Guide to the Cartagena Protocol on Biosafety.

IUCN Environmental Policy and Law Paper No.

46.

IUCN – The World Conservation Union, Gland.

http://www.iucn.org/themes/law/ pdfdocuments/Biosafety-guide.pdf Makanya, Z.
(2004).Twelve reasons why GMO crops are not favorable in African Agriculture.

http://www.peoplesearthdecade.org/articles/ article.php?id=298 Manos-Jones, M. (2004).

Caterpillar Dreaming Butterfly.

http://www.learner.org/jnorth/tm/monarch/CaterpillarDreamStoryMMJ.

html Mansour, S. (2005).

Egypt Biotechnology Annual Agricultural Biotechnology Report.

USDA Foreign Agricultural Service GAIN Report Number: EG5013.
http://www.fas.usda.gov/gainfiles/200508/ 146130612.doc Mayet, M. (2003).Why Africa should adopt the OAU African Model Law on Safety in Biotechnology.African Centre for Biosafety.

http://www.biosafetyafrica.net/_DOCS/CommentBiosafetyModelLaw.pdf Mills, C. (2005).

Could genetically modified foods be a new source of allergens?

http://www.scidev.net/dossiers/index.cfm?fuseaction= printarticle&dossier=6&policy=56 Mohamed-Katerere, J.C. (2003).

Risk and rights: challenging biotechnology policy in Zimbabwe.
IDS Working Paper 204.

Institute of Development Studies, Brighton.

http://www.ids.ac.uk/ids/bookshop/ wp/wp204.pdf Monroe, D. (2004).

GM Pollen Spreads Much Farther Than Previously Thought.

Scientific American, Science News, 21 September.

http://www.sciam.com/article.cfm?chanID=sa003&articleID=000979 00-4691-114F-84F583414B7F4945 Muir, J.

(2003).

Improving Family Nutrition.

Id21 insights: communicating development research, Issue Health No.
5. http://www.id21.org/insights/insights-h05/insights-issh05-art03.html National Research Council (1996).

Lost Crops of Africa:Volume I: Grains.

National Academy Press,Washington, D.C. Ngandwe,T.

(2005).

Zambia builds high-tech lab to detect GM food imports.

SciDev Net News, 13 May.

http://www.scidev.net/content/ news/eng/zambia-builds-high-tech-lab-to-detect-gm-food- imports.cfm Nuffield Council on Bioethics (1999).

Genetically Modified Crops: the Ethical and Social Issues.
Nuffield Council on Bioethics, London.

http://www.nuffieldbioethics.org/fileLibrary/pdf/gmcrop.pdf Odame, H., Kameri-Mbote, P. and Wafula, D. (2003).

Governing Modern Agricultural Biotechnology in Kenya: Implications for Food Security.

IDS Working Paper 199.

Institute of Development Studies, Brighton.

http://www.ids.ac.uk/ids/bookshop/wp/wp199.pdf Odhiambo,T.R.

(2001).African Agriculture and Medicine: Modern Orphans in a Globalizing World.ActionBioscience.org.
http://www.actionbioscience.org/newfrontiers/odhiambo.html Porter, L. (2005).

Lawmakers again turn their attention to GMOs.

Vermont Press Bureau, 10 February.

http://gefreevt.org/index.php?

name=news&ID=205 330 AFRICA ENVIRONMENT OUTLOOK 2 ● OUR ENVIRONMENT, OUR WEALTH Portfolio 21 (2005).

Biotechnology Policy for Portfolio 21. http://www.portfolio21.com/Biotech-main.html WCED (1987).

Our Common Future.World Commission on Environment and Development.

Oxford University Press, Oxford Pruzin, D. (2004).


6-Regulation:WTO Chief Appoints Panelists To Rule on EU GMO Restrictions.

Bureau of National Affairs, International Trade Daily, 5 May.

http://www.gene.ch/genet/2004/Mar/msg00022.html WHO (2005).

Modern food biotechnology, human health and development: an evidence based study.World Health Organization, Geneva.

http://www.who.int/foodsafety/publications/biotech/biotech_en.pdf Pschorn-Strauss, E. (2005).
Bt cotton in South Africa.The case of the Makhathini Farmers.

Seedling.April 2005. http://www.grain.org/seedling_files/seed-05-04-3.pdf Witcombe, J and Sanchez, J (2004).

Food systems and security helping the poor cope.

ID21 health.

http://www.id21.org/health/InsightsHealth 5art3.html Reuters (2005).

Poland to Ban Monsanto GMO Maize Seed.

Reuters News Service, 23 March.

http://www.planetark.com/dailynewsstory.

cfm/newsid/30052/story.htm Yamin, F. (2003).


Intellectual property rights, biotechnology and food security.

IDS Working Paper 203. http://www.ids.ac.uk/ids/bookshop/ wp/wp203.pdf Young,T.

(2004).

Genetically Modified Organisms and Biosafety: A background paper for decision-makers and others to assist in consideration of GMO issues.

IUCN – The World Conservation Union, Gland.

http://www.iucn.org/themes/law/pdfdocuments/GMO_English.pdf Riddle, J.A.

(2002).
(2002).

10 Strategies to Minimize Risks of GMO Contamination.

http://www.newfarm.org/features/0802/strategies.shtml SADC (2004).

SADC Today, 7 (1).

Southern African Development Community.

Sawahel,W.

(2005).

GM cassava uses viral gene to fight disease.

SciDev.Net News, 15 July.

http://www.scidev.net/content/news/eng/ gm-cassava-uses-viral-gene-to-fight-disease.cfm Scoones, I.

(2005).

Governing Technology Development: Challenges for Agricultural Research in Africa.

IDS Bulletin, 36 (2), 109-14.


Institute of Development Studies, Brighton.

Scoones, I.

(2002).

Science, policy and regulation: challenges for agricultural biotechnology in developing countries.

IDS Working Paper 147.

Institute of Development Studies, Brighton.

http://www.ids.ac.uk/ ids/bookshop/wp/wp147.pdf Secretariat of the CBD (2000).

Cartagena Protocol on Biosafety to the Convention on Biological Diversity – Text and Annexes.

Secretariat of the Convention on Biological Diversity, Montreal.
http://www.biodiv.org/ doc/legal/cartagena-protocol-en.pdf Seshia, S. (2002).

Plant Variety Protection and Farmers’ Rights in India: Law-Making and the Cultivation of Varietal Control.

Economic and Political Weekly.

37 (27), 2741-7. http://www.ids.ac.uk/ids/knots/ PDFs/EPWarticle_Shaila.pdf Soil Association (2003a).

GM crops are economic disaster shows new report.

Press Release, 6 May.


http://www.soilassociation.org/web/sa/ saweb.nsf/0/80256ad80055454980256c320058c60e?OpenDocument Soil Association (2003b).Key Concerns about GM.Press Statement,6 May.

http://www.soilassociation.org/web/sa/saweb.nsf/librarytitles/05062003.

html Spinney,L.

(1999).Biotechnology in Crops:Issues for the developing world.

A report compiled for Oxfam GB by Laura Spinney.Oxfam GB,Oxford.

http://www.oxfam.org.uk/what_we_do/issues/livelihoods/biotech_gm.htm UN (1992).
Convention on Biological Diversity (with annexes), Concluded at Rio de Janeiro on 5 June 1992.

United Nations Treaty Series No.

30619. http://www.biodiv.org/doc/legal/cbd-un-en.pdf UN Millennium Project (2005a).

Environment and Human Well-being:A Practical Strategy.

Report of the Task Force on Environmental Sustainability.

Earthscan, London.

http://www.unmillenniumproject.

org/documents/Environment-complete-lowres.pdf UN Millennium Project (2005b).
Innovation:Applying Knowledge in Development.Task Force on Science,Technology, and Innovation.

Earthscan, London.

http://www.unmillenniumproject.org/documents/ Science-complete.pdf University of Arizona/College of Agriculture and Life Sciences (2003).

Gemini Detective.

Gemiviridae: Bogomoviruses whitefly-transmitted geminiviruses.

http://gemini.biosci.arizona.edu/viruses/acmv/